<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotics for acute rhinosinusitis in adults - Lemiengre, MB - 2018 | Cochrane Library</title> <meta content="Antibiotics for acute rhinosinusitis in adults - Lemiengre, MB - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotics for acute rhinosinusitis in adults - Lemiengre, MB - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006089.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotics for acute rhinosinusitis in adults" name="citation_title"/> <meta content="Marieke B Lemiengre" name="citation_author"/> <meta content="Ghent University" name="citation_author_institution"/> <meta content="marieke.lemiengre@ugent.be" name="citation_author_email"/> <meta content="Mieke L van Driel" name="citation_author"/> <meta content="Dan Merenstein" name="citation_author"/> <meta content="Georgetown University Medical Center" name="citation_author_institution"/> <meta content="Helena Liira" name="citation_author"/> <meta content="University of Helsinki" name="citation_author_institution"/> <meta content="Marjukka Mäkelä" name="citation_author"/> <meta content="An IM De Sutter" name="citation_author"/> <meta content="Ghent University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD006089.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/09/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti‐Bacterial Agents [*therapeutic use]; Radiography; Randomized Controlled Trials as Topic; Rhinitis [diagnostic imaging, *drug therapy]; Sinusitis [diagnostic imaging, *drug therapy]; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006089.pub5&amp;doi=10.1002/14651858.CD006089.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006089\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006089\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","ms","fr","th","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006089.pub5",title:"Antibiotics for acute rhinosinusitis in adults",firstPublishedDate:"Sep 10, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006089.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006089.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006089.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006089.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006089.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006089.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006089.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006089.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006089.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006089.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17862 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006089.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0118"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0068"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-sec-0112"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/appendices#CD006089-sec-0123"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/table_n/CD006089StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/table_n/CD006089StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotics for acute rhinosinusitis in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Marieke B Lemiengre</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0003">Mieke L van Driel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0004">Dan Merenstein</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0005">Helena Liira</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0006">Marjukka Mäkelä</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information#CD006089-cr-0007">An IM De Sutter</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information/en#CD006089-sec-0132">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 September 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006089.pub5">https://doi.org/10.1002/14651858.CD006089.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006089-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006089-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006089-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006089-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006089-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD006089-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006089-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006089-abs-0001" lang="en"> <section id="CD006089-sec-0001"> <h3 class="title" id="CD006089-sec-0001">Background</h3> <p>Acute rhinosinusitis is an acute infection of the nasal passages and paranasal sinuses that lasts less than four weeks. Diagnosis of acute rhinosinusitis is generally based on clinical signs and symptoms in ambulatory care settings. Technical investigations are not routinely performed, nor are they recommended in most countries. Some trials show a trend in favour of antibiotics, but the balance of benefit versus harm is unclear. </p> <p>We merged two Cochrane Reviews for this update, which comprised different approaches with overlapping populations, resulting in different conclusions. For this review update, we maintained the distinction between populations diagnosed by clinical signs and symptoms, or imaging. </p> </section> <section id="CD006089-sec-0002"> <h3 class="title" id="CD006089-sec-0002">Objectives</h3> <p>To assess the effects of antibiotics versus placebo or no treatment in adults with acute rhinosinusitis in ambulatory care settings. </p> </section> <section id="CD006089-sec-0003"> <h3 class="title" id="CD006089-sec-0003">Search methods</h3> <p>We searched CENTRAL (2017, Issue 12), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (January 1950 to January 2018), Embase (January 1974 to January 2018), and two trials registers (January 2018). We also checked references from identified trials, systematic reviews, and relevant guidelines. </p> </section> <section id="CD006089-sec-0004"> <h3 class="title" id="CD006089-sec-0004">Selection criteria</h3> <p>Randomised controlled trials of antibiotics versus placebo or no treatment in people with rhinosinusitis‐like signs or symptoms or sinusitis confirmed by imaging. </p> </section> <section id="CD006089-sec-0005"> <h3 class="title" id="CD006089-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data about cure and side effects and assessed the risk of bias. We contacted trial authors for additional information as required. </p> </section> <section id="CD006089-sec-0006"> <h3 class="title" id="CD006089-sec-0006">Main results</h3> <p>We included 15 trials involving 3057 participants. Of the 15 included trials, 10 appeared in our 2012 review, and five (631 participants) are legacy trials from merging two reviews. No new studies were included from searches for this update. Overall, risk of bias was low. Without antibiotics, 46% of participants with rhinosinusitis, whether or not confirmed by radiography, were cured after 1 week and 64% after 14 days. Antibiotics can shorten time to cure, but only 5 to 11 more people per 100 will be cured faster if they receive antibiotics instead of placebo or no treatment: clinical diagnosis (odds ratio (OR) 1.25, 95% confidence interval (CI) 1.02 to 1.54; number needed to treat for an additional beneficial outcome (NNTB) 19, 95% CI 10 to 205; I² = 0%; 8 trials; high‐quality evidence) and diagnosis confirmed by radiography (OR 1.57, 95% CI 1.03 to 2.39; NNTB 10, 95% CI 5 to 136; I² = 0%; 3 trials; moderate‐quality evidence). Cure rates with antibiotics were higher when a fluid level or total opacification in any sinus was found on computed tomography (OR 4.89, 95% CI 1.75 to 13.72; NNTB 4, 95% CI 2 to 15; 1 trial; moderate‐quality evidence). Purulent secretion resolved faster with antibiotics (OR 1.58, 95% CI 1.13 to 2.22; NNTB 10, 95% CI 6 to 35; I² = 0%; 3 trials; high‐quality evidence). However, 13 more people experienced side effects with antibiotics compared to placebo or no treatment (OR 2.21, 95% CI 1.74 to 2.82; number needed to treat for an additional harmful outcome (NNTH) 8, 95% CI 6 to 12; I² = 16%; 10 trials; high‐quality evidence). Five fewer people per 100 will experience clinical failure if they receive antibiotics instead of placebo or no treatment (Peto OR 0.48, 95% CI 0.36 to 0.63; NNTH 19, 95% CI 15 to 27; I² = 21%; 12 trials; high‐quality evidence). A disease‐related complication (brain abscess) occurred in one participant (of 3057) one week after receiving open antibiotic therapy (clinical failure, control group). </p> </section> <section id="CD006089-sec-0007"> <h3 class="title" id="CD006089-sec-0007">Authors' conclusions</h3> <p>The potential benefit of antibiotics to treat acute rhinosinusitis diagnosed either clinically (low risk of bias, high‐quality evidence) or confirmed by imaging (low to unclear risk of bias, moderate‐quality evidence) is marginal and needs to be seen in the context of the risk of adverse effects. Considering antibiotic resistance, and the very low incidence of serious complications, we conclude there is no place for antibiotics for people with uncomplicated acute rhinosinusitis. We could not draw conclusions about children, people with suppressed immune systems, and those with severe sinusitis, because these populations were not included in the available trials. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006089-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006089-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006089-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006089-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006089-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006089-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006089-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006089-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD006089-abs-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006089-abs-0016">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006089-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006089-abs-0003" lang="en"> <h3>Antibiotics for sinus infection of short duration in adults</h3> <p><b>Review question</b> </p> <p>Do antibiotics cure sinus infection faster than no antibiotics in adults?</p> <p><b>Background</b> </p> <p>A sinus is a cavity situated in the head. Adults with short‐duration sinus infection experience stuffy nose and thick, yellow discharge from the nose. People with sinus infection can feel slime in the back of the throat, facial pain, pain when bending forward, and pain in the upper teeth or when chewing. A short‐duration sinus infection may be suspected following physical examination and questions about symptoms. Blood examination or images of the sinuses can support diagnosis, but are not routinely recommended in most countries. Short‐duration sinus infections are mostly caused by viruses. Nevertheless, physicians tend to prescribe antibiotics, which should only be used to treat bacterial infections. Taking antibiotics unnecessarily results in antibiotic resistance against bacterial infections. We investigated whether antibiotics cure adults with short‐duration sinus infection faster than a dummy drug (placebo) or no treatment. </p> <p><b>Search date</b> </p> <p>18 January 2018.</p> <p><b>Study characteristics</b> </p> <p>We included 15 studies in which adults with short‐duration sinus infection, whether or not confirmed by imaging, randomly received antibiotics, or a dummy drug or no treatment, in ambulatory care settings. The studies included a total of 3057 adults whose average age was 36 years; about 60% were female. Participants were followed until they were cured. Trial duration ranged from 8 to 28 days. </p> <p><b>Study funding sources</b> </p> <p>Seven studies received financial support from government or academic institutions; six received grants from the pharmaceutical industry; and five did not state sources of support. </p> <p><b>Key results</b> </p> <p>Without antibiotics, almost half of all participants were cured after one week, and two out of three were cured after 14 days. Five (diagnosis based on symptoms described to a doctor) to 11 (diagnosis confirmed by x‐ray) more people per 100 were cured faster with antibiotics. A computed tomography (CT) scan could better predict who would benefit from antibiotics, but routine use would cause health problems related to radiation exposure. Ten more people per 100 were relieved faster of thick, yellow discharge from the nose with antibiotics compared to a dummy drug or no treatment. Thirteen more people per 100 experienced side effects (mostly concerning stomach or intestines) with antibiotics compared to a dummy drug or no treatment. Compared with people who initially started antibiotics, five more people per 100 in the dummy drug or no treatment group had to start antibiotics because their condition worsened. Serious complications (e.g. brain abscess) were rare. </p> <p>We found that antibiotics are not a first‐choice treatment for adults with short‐duration sinus infection. We found no evidence relating to adults with severe sinusitis or with reduced immunity, or to children. </p> <p><b>Quality of evidence</b> </p> <p>We found high‐quality evidence when the diagnosis was based on symptoms described to a doctor. We downgraded evidence quality to moderate when diagnosis was confirmed by x‐ray or CT scan because the number of participants was small, which makes the estimates less reliable. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006089-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006089-sec-0118"></div> <h3 class="title" id="CD006089-sec-0119">Implications for practice</h3> <section id="CD006089-sec-0119"> <p>Our review showed that there could be a beneficial therapeutic effect of antibiotics in adults with clinically diagnosed acute rhinosinusitis. But this effect is small, and only around 5 more people per 100 will be cured faster if they receive antibiotics instead of placebo. The lack of effect of antibiotics could be related to the non‐specificity of the clinical presentation of acute bacterial sinusitis. Performing radiography increases this number from 5 to 11 per 100. In adults with a fluid level or total opacification present on computed tomography, 28 more people per 100 cured faster with antibiotics. In clinically diagnosed rhinosinusitis, the subgroup of people with purulent discharge could benefit slightly more than those without. However, the benefits need to be seen in the context of the risk of experiencing adverse effects, especially of a gastrointestinal nature, and health risks of radiation exposure. Five fewer people per 100 will experience clinical failure if they receive antibiotics instead of placebo. This review addresses mainly people assessed in a ambulatory care setting and excluded people who were investigated further with laboratory tests. Considering the worldwide high antibiotic prescription rate for rhinosinusitis, growing antibiotic resistance, and the very low incidence of complications, we can conclude that there is no place for the use of antibiotics in adults with uncomplicated acute rhinosinusitis. For subgroups that are potentially more vulnerable, such as children, adults with a suppressed immune system, and adults with severe sinusitis (e.g. very high fever, prolonged symptoms, findings suggestive of severe sepsis such as hypotension) and people referred to an ear, nose, and throat specialist because of confirmed or perceived complications, no evidence is available from randomised, placebo‐controlled trials. Complications are so rare (1/3057 participants in our review) that only case reports can give information about their course, hence evidence that serious complications can be prevented by giving antibiotics early is lacking. </p> </section> <h3 class="title" id="CD006089-sec-0120">Implications for research</h3> <section id="CD006089-sec-0120"> <p>Despite the availability of several studies and meta‐analyses, there is still insufficient clinical data to enable subgroup analysis of people who probably could benefit more from antibiotics, for example people with high fever, severe facial pain, or rhinorrhoea. It may be unlikely that such data will become available, as they pose ethical (exposing vulnerable people to placebo treatment) and feasibility (a relatively small group that would take a long time to collect data) issues. Better recording of routinely collected data and morbidity, as well as adverse drug reaction registers, might be helpful in answering this question. The possibility of C‐reactive protein (CRP) measurement or bacteriological investigations to select people that benefit from antibiotics should be further explored. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006089-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006089-sec-0036"></div> <div class="table" id="CD006089-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to placebo for acute rhinosinusitis in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antbiotics compared to placebo for acute rhinosinusitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging<br/> <b>Settings:</b> general practice (11 studies), otolaryngology outpatient clinics of university hospitals (2 studies), medical centre (1 study), unknown (2 studies)<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with clinically diagnosed acute rhinosinusitis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b><br/> (56 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.25</b> <br/> (1.02 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1687<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combination of sinusitis‐like symptoms. Most frequently used clinical symptoms: nasal discharge, facial pain, and common cold or upper respiratory tract infection. </p> <p>NNTB 19 (95% CI 10 to 205)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with acute rhinosinusitis confirmed by radiography<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 100</b> </p> <p>(52 to 72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.57</b> </p> <p>(1.03 to 2.39)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>394</p> <p>(3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>Moderate<sup>2, 3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical suspicion + radiography, using various criteria:</p> <p> <ul id="CD006089-list-0001"> <li> <p>confirmed secretion;</p> </li> <li> <p>&gt; 5 mm mucosal thickening, opacity or fluid level; or</p> </li> <li> <p>the presence in at least 1 sinus of an air‐fluid level, a complete opacity, or a mucosal thickening of 10 mL. </p> </li> </ul> </p> <p>NNTB 10 (95% CI 5 to 136)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with acute rhinosinusitis confirmed by computed tomography<sup>1,4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 100</b> </p> <p>(18 to 64)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 4.89</b> </p> <p>(1.75 to 13.72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>5</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical suspicion + computed tomography, using as a criterion presence of fluid level or total opacification in any sinus </p> <p>NNTB 4 (95% CI 2 to 15)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severity or duration of different clinical symptoms: resolution of purulent secretion</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 100</b><br/> (63 to 77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.58</b> <br/> (1.13 to 2.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>660<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTB 10 (95% CI 6 to 35)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects: total</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 100</b><br/> (24 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.21</b> </p> <p>(1.74 to 2.82)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1816<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 8 (95% CI 6 to 12)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects: diarrhoea</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 100</b><br/> (13 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 2.00</b> </p> <p>(1.41 to 2.85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1210<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 13 (95% CI 8 to 29)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical failure</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 100</b><br/> (4 to 8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.48</b> </p> <p>(0.36 to 0.63)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2603<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 19 (95% CI 15 to 27)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NNTB:</b> number needed to treat for an additional beneficial outcome; <b>NNTH:</b> number needed to treat for an additional harmful outcome; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Only outcomes that could be pooled were presented.</p> <p><sup>1</sup>High heterogeneity (I² = 41%) for the outcome of cure in adults with acute rhinosinusitis confirmed by imaging led us to split the outcome into cure in adults with acute rhinosinusitis confirmed by radiography and cure in adults with acute rhinosinusitis confirmed by computed tomography.<br/> <sup>2</sup>There was a high risk of blinding bias in <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>. Blinding was not reported and was probably not applied. Placebo group participants did not receive tablets, only nose drops. It was not possible to blind sinus irrigation as an intervention. Only group 2 participants underwent radiological evaluation every second day. Group 3 participants received a longer course of tablets than group 4. For this reason, we downgraded the quality of evidence from high to moderate. Omitting this trial from the meta‐analysis did not substantially change the overall result; therefore, we did not downgrade the quality of the evidence further.<br/> <sup>3</sup>Three trials reported cure in adults with acute rhinosinusitis confirmed by radiography, and confidence intervals were wide. We downgraded the quality of the evidence to moderate.<br/> <sup>4</sup><a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> presented study results from two distinct groups (those with fluid level or total opacification in any sinus on computed tomography and those with only mucosal thickening on computed tomography, respectively). Consequently, the results of the two trials were very different (I² = 84%). We opted to report only the results from <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> because the beneficial effect of antibiotics was clearly present only in this subgroup.<br/> <sup>5</sup>Only one trial (N = 127) reported on cure in adults with acute rhinosinusitis confirmed by computed tomography. We downgraded the quality of the evidence to moderate because of the low number of participants despite this being a well‐conducted trial. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006089-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006089-sec-0037"></div> <p>We merged two Cochrane Reviews for this update (<a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>; <a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>). </p> <section id="CD006089-sec-0038"> <h3 class="title" id="CD006089-sec-0038">Description of the condition</h3> <p>Acute rhinosinusitis is defined as an acute infection of the nasal passages and the paranasal sinuses lasting fewer than four weeks (<a href="./references#CD006089-bbs2-0021" title="Ah‐SeeKW , EvansAS . Sinusitis and its management. BMJ2007;334:358‐61. ">Ah‐See 2007</a>; <a href="./references#CD006089-bbs2-0047" title="LanzaDC , KennedyDW . Adult rhinosinusitis defined. Otolaryngology Head and Neck Surgery1997;117(3 Suppl 2):1‐7. ">Lanza 1997</a>). It is one of the most common diagnoses made in ambulatory care and continues to be a clinical challenge (<a href="./references#CD006089-bbs2-0027" title="BlackwellDL , LucasJW , ClarkeTC . Summary health statistics for U.S. adults: national health interview survey, 2012. Vital and Health Statistics. Series 10, Data from the National Health Survey2014;10(260):1‐161. [PUBMED: 24819891] ">Blackwell 2014</a>; <a href="./references#CD006089-bbs2-0048" title="Lethbridge‐CejkuM , RoseD , VickerieJ . Summary health statistics for US adults: national health interview survey, 2004. Vital and Health Statistics. Series 10, Data from the National Health Survey2006;10(228):19‐22. ">Lethbridge‐Cejku 2006</a>; <a href="./references#CD006089-bbs2-0052" title="McCaigLF , HughesJM . Trends in antimicrobial drug prescribing among office‐based physicians in the United States. JAMA1995;273(3):214‐9. ">McCaig 1995</a>; <a href="./references#CD006089-bbs2-0055" title="OkkesI , OskamS , VanBovenK . EFP. Episodes of care in Dutch family practice. Epidemiological data based on the routine use of the International Classification of Primary Care (ICPC) in the Transition Project of the Academic Medical Center, University of Amsterdam (1985 to 2003). www.transhis.nl. Login required. Amsterdam: Academic Medical Center/University of Amsterdam, Department of Family Medicine, (accessed prior to 10 August 2018). ">Okkes 2005</a>; <a href="./references#CD006089-bbs2-0059" title="SchappertSM . Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. Vital and Health Statistics. Series 13, Data from the National Health Survey1998;13(134):1‐37. ">Schappert 1998</a>; <a href="./references#CD006089-bbs2-0063" title="WilletLR , CarsonJL , WilliamsJWJr . Current diagnosis and management of sinusitis. Journal of General Internal Medicine1994;9(1):38‐45. ">Willet 1994</a>). Although guidelines have long recommended restricted use of antibiotics for rhinosinusitis, antibiotics continue to be prescribed for 67% to 100% of people with suspected acute rhinosinusitis (<a href="./references#CD006089-bbs2-0037" title="GullifordMC , DreganA , MooreMV , AshworthM , StaaTv , McCannG , et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open2014;4(10):e006245. [DOI: 10.1136/bmjopen‐2014‐006245] ">Gulliford 2014</a> (UK); <a href="./references#CD006089-bbs2-0058" title="Rún SigurðardóttirN , NielsenAB , MunckA , BjerrumL . Appropriateness of antibiotic prescribing for upper respiratory tract infections in general practice: comparison between Denmark and Iceland. Scandinavian Journal of Primary Health Care2015;33(4):269‐74. [DOI: 10.3109/02813432.2015.1114349] ">Rún 2015</a> (Denmark, Iceland); <a href="./references#CD006089-bbs2-0033" title="Fleming‐DutraKE , HershAL , ShapiroDJ , BartocesM , EnnsEA , FileTMJr , et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010‐2011. JAMA2016;315(17):1864‐73. [DOI: 10.1001/jama.2016.4151] ">Fleming‐Dutra 2016</a> (USA)). </p> <p>Rhinosinusitis is a more exact term than sinusitis since it takes into account that inflammation of the sinuses is unlikely to occur without inflammation of the mucous membranes of the nose. In this review, the term 'sinusitis' was used when inflammation of a specific sinus (confirmed by radiology or ultrasound) was mentioned (e.g. maxillary sinusitis). Sinusitis was often used in older studies when referring to rhinosinusitis. </p> <p>Typical signs and symptoms of acute rhinosinusitis include purulent nasal discharge, postnasal drip, sinus pain at palpation, unilateral facial pain, and maxillary toothache (<a href="./references#CD006089-bbs2-0023" title="AutioTJ , KoskenkorvaT , NärkiöM , LeinoTK , KoivunenP , AlhoOP . Diagnostic accuracy of history and physical examination in bacterial acute rhinosinusitis. Laryngoscope2015;125(7):1541‐6. [DOI: 10.1002/lary.25247] ">Autio 2015</a>; <a href="./references#CD006089-bbs2-0024" title="AxelssonA , ChidekelN . Symptomatology and bacteriology correlated to radiological findings in acute maxillary sinusitis. Acta Oto‐laryngologica1972;74(1):118‐22. ">Axelsson 1972</a>; <a href="./references#CD006089-bbs2-0064" title="WilliamsJWJ , SimelDL . Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA1993;270(10):1242‐6. ">Williams 1993</a>). However, there is no convincing evidence that people with these clinical findings would benefit from antibiotic treatment (<a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a>). Bacterial infections can also be self limiting. Imaging investigations, such as x‐ray and computed tomography (CT), have been used to demonstrate fluid in the sinuses (air‐fluid level or total opacity). Sinus ultrasound has also been used for this purpose in Scandinavia (<a href="./references#CD006089-bbs2-0061" title="VaronenH , MäkeläM , SavolainenS , LääräE , HildenJ . Comparison of ultrasound, radiography, and clinical examination in the diagnosis of acute maxillary sinusitis: a systematic review. Journal of Clinical Epidemiology2000;53(9):940‐8. [PUBMED: 11004420 ] ">Varonen 2000</a>). However, radiological methods cause radiation, are not readily available in ambulatory care settings, and cannot differentiate between viral and bacterial infections. Rhinosinusitis could be confirmed by sinus puncture (<a href="./references#CD006089-bbs2-0049" title="LindbaekM , HjortdahlP . The clinical diagnosis of acute purulent sinusitis in general practice ‐ a review. British Journal of General Practice2002;52(479):491‐5. ">Lindbaek 2002</a>), but this is not a feasible ambulatory care method. Acute rhinosinusitis remains a clinical diagnosis with a non‐specific clinical picture. </p> </section> <section id="CD006089-sec-0039"> <h3 class="title" id="CD006089-sec-0039">Description of the intervention</h3> <p>We investigated the effectiveness of antibiotics versus placebo or no treatment in adults with acute rhinosinusitis, whether diagnosed clinically or by imaging. </p> <p>Two previous Cochrane Reviews ('Antibiotics for acute maxillary sinusitis in adults' and 'Antibiotics for clinically diagnosed acute rhinosinusitis in adults') described the effect of antibiotics for acute rhinosinusitis (<a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>; <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>). The reviews studied the same condition but looked at different populations: people diagnosed by imaging versus people diagnosed clinically according to their signs and symptoms (<a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>; <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>). As different approaches resulted in different conclusions, we therefore merged these reviews while maintaining the relevant distinction between the two populations. We omitted comparison between antibiotics, as assessed by <a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>. Rather than clinical trials, local up‐to‐date antibiotic resistance patterns should guide clinicians in making the best choice of a particular antibiotic and dose in the subgroup of people with suspected bacterial rhinosinusitis. </p> <p>Two other Cochrane Reviews focused on antibiotic treatment for people with acute infections of the nose, sinuses, or both (<a href="./references#CD006089-bbs2-0045" title="KenealyT , ArrollB . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Kenealy 2013</a>; <a href="./references#CD006089-bbs2-0054" title="MorrisP , LeachA . Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001094.pub2] ">Morris 2002</a>). Kenealy and colleagues looked at the effect of antibiotics in people with symptoms of acute upper respiratory tract infection lasting less than seven days, or acute purulent rhinitis of less than 10 days duration (<a href="./references#CD006089-bbs2-0045" title="KenealyT , ArrollB . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Kenealy 2013</a>). The authors concluded that there was insufficient evidence to warrant the use of antibiotics for common cold or for persisting acute purulent rhinitis in children or adults (<a href="./references#CD006089-bbs2-0045" title="KenealyT , ArrollB . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Kenealy 2013</a>). Morris and colleagues considered antibiotic treatment in children with persistent nasal discharge (<a href="./references#CD006089-bbs2-0054" title="MorrisP , LeachA . Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001094.pub2] ">Morris 2002</a>). The authors concluded that antibiotics have some benefit in the short and medium term in children with purulent rhinorrhoea for more than 10 days, or in older children with radiologically confirmed rhinosinusitis (<a href="./references#CD006089-bbs2-0054" title="MorrisP , LeachA . Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001094.pub2] ">Morris 2002</a>). </p> </section> <section id="CD006089-sec-0040"> <h3 class="title" id="CD006089-sec-0040">How the intervention might work</h3> <p>Acute rhinosinusitis can be caused by viral or bacterial infections. Acute viral rhinosinusitis is a viral upper respiratory tract infection (or common cold) which, in most cases, also involves the sinuses. <a href="./references#CD006089-bbs2-0038" title="GwaltneyJMJr , PhillipsCD , MillerRD , RikerD . Computed tomographic study of the common cold. New England Journal of Medicine1994;330(1):25‐30. ">Gwaltney 1994</a> showed that 87% of people with a common cold also have sinus abnormalities on CT scan. Antibiotics are unnecessary in viral rhinosinusitis (<a href="./references#CD006089-bbs2-0042" title="HicknerJM , BartlettJG , BesserRE , GonzalesR , HoffmanJR , SandeMA . Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine2001;134(6):498‐505. ">Hickner 2001</a>), and people prescribed an antibiotic can develop bacterial resistance to that antibiotic (<a href="./references#CD006089-bbs2-0030" title="CostelloeC , MetcalfeC , LoveringA , MantD , HayAD . Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta‐analysis. BMJ2010;340:c2096. [DOI: 10.1136/bmj.c2096] ">Costelloe 2010</a>). </p> <p>Few people (0.5% to 2%) develop bacterial rhinosinusitis (<a href="./references#CD006089-bbs2-0026" title="BergO , CarenfeltC , RystedtG , AnggärdA . Occurence of asymptomatic sinusitis in common cold and other acute ENT‐infections. Rhinology1986;24(3):223‐5. ">Berg 1986</a>; <a href="./references#CD006089-bbs2-0039" title="GwaltneyJMJr . Acute community‐acquired sinusitis. Clinical Infectious Diseases1996;23(6):1209‐23. ">Gwaltney 1996</a>). Antibiotics may be indicated for bacterial rhinosinusitis to speed up recovery or to prevent suppurative complications. Identifying people with bacterial rhinosinusitis on a clinical basis is challenging (<a href="./references#CD006089-bbs2-0031" title="EbellMH , HansenJG . Proposed clinical decision rules to diagnose acute rhinosinusitis among adults in primary care. Annals of Family Medicine2017;15(4):347‐54. [DOI: 10.1370/afm.2060] ">Ebell 2017</a>; <a href="./references#CD006089-bbs2-0049" title="LindbaekM , HjortdahlP . The clinical diagnosis of acute purulent sinusitis in general practice ‐ a review. British Journal of General Practice2002;52(479):491‐5. ">Lindbaek 2002</a>). Bacterial origin may be more likely if symptoms last for more than a week (<a href="./references#CD006089-bbs2-0040" title="GwaltneyJMJr . Sinusitis. In: MandellGL , BennettJE , DolinR editor(s). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Elsevier, 2005:772‐83. ">Gwaltney 2005</a>). Consequently, the notions of 'viral' and 'bacterial' are not very workable in daily practice, and there is a pressing need to identify who would benefit from antibiotics (<a href="./references#CD006089-bbs2-0047" title="LanzaDC , KennedyDW . Adult rhinosinusitis defined. Otolaryngology Head and Neck Surgery1997;117(3 Suppl 2):1‐7. ">Lanza 1997</a>). </p> </section> <section id="CD006089-sec-0041"> <h3 class="title" id="CD006089-sec-0041">Why it is important to do this review</h3> <p>Diagnosis of most people with acute rhinosinusitis who present in ambulatory care settings is based on clinical signs and symptoms. In most countries, technical investigations are not routinely performed, nor are they recommended (<a href="./references#CD006089-bbs2-0028" title="BrazzelliMG , AstinMP . Making the Best Use of Department of Clinical Radiology. Guidelines for Doctors. 5th Edition. London: Royal College of Radiologists, 2003. ">Brazzelli 2003</a>; <a href="./references#CD006089-bbs2-0042" title="HicknerJM , BartlettJG , BesserRE , GonzalesR , HoffmanJR , SandeMA . Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine2001;134(6):498‐505. ">Hickner 2001</a>; <a href="./references#CD006089-bbs2-0051" title="LowDE , DesroiresM , McSherryJ , GarberG , WilliamsJW , RemyH , et al. A practical guide for the diagnosis and treatment of acute sinusitis. Canadian Medical Association Journal1997;156(Suppl 6):1‐14. ">Low 1997</a>). Except for the Cochrane Reviews that are part of this amalgamation (<a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>; <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>), two other previously published Cochrane Reviews did not focus exclusively on adults or people with suspected rhinosinusitis (<a href="./references#CD006089-bbs2-0045" title="KenealyT , ArrollB . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Kenealy 2013</a>; <a href="./references#CD006089-bbs2-0054" title="MorrisP , LeachA . Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001094.pub2] ">Morris 2002</a>). Results from those reviews could therefore not indicate if this population should be treated with antibiotics. Individual trials show a trend in favour of antibiotics for this population, but the balance of benefit versus harm is unclear. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006089-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006089-sec-0042"></div> <p>To assess the effects of antibiotics versus placebo in adults with acute rhinosinusitis in ambulatory care settings. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006089-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006089-sec-0043"></div> <section id="CD006089-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006089-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) comparing antibiotics with placebo or no treatment in participants with rhinosinusitis‐like signs or symptoms, whether confirmed by imaging or not. We considered trials including participants with an upper respiratory tract infection or common cold if most participants had rhinosinusitis‐like symptoms, or if participants with rhinosinusitis‐like symptoms could be analysed separately. </p> <p>We excluded the following studies.</p> <p> <ol id="CD006089-list-0002"> <li> <p>Trials in which participants were included on the basis of a laboratory investigations such as measurement of C‐reactive protein (CRP) or erythrocyte sedimentation rate (ESR), bacteriological or cytological investigations. </p> </li> <li> <p>Studies comparing one antibiotic with another and trials comparing antibiotics versus other medications. </p> </li> <li> <p>Trials in which more than 50% of participants were considered to have a common cold.</p> </li> <li> <p>Trials in which participants had signs and symptoms for more than 30 days.</p> </li> <li> <p>Trials in which participants were not randomised, or trials that did not include a placebo arm. </p> </li> </ol> </p> </section> <section id="CD006089-sec-0046"> <h4 class="title">Types of participants</h4> <p>We considered all trials in which adults with acute rhinosinusitis, whether clinically diagnosed or confirmed by imaging, were randomly assigned to treatment with an antibiotic, placebo, or no treatment. The clinical diagnosis of acute rhinosinusitis was based on the presence of clinical signs or symptoms that are associated with the presence of fluid in the sinuses in diagnostic studies or that are mentioned in clinical practice guidelines as indicating rhinosinusitis. These included: started with a common cold or experienced both phases of the illness (i.e. catches a cold, feels better after a few days, then feels worse again), purulent nasal discharge, unilateral maxillary pain, pain in the upper teeth, pain when chewing, postnasal drip, pain on bending forward, and duration of symptoms for more than seven days. </p> <p>We limited participants to adults (aged 18 years or over); the Cochrane Review by <a href="./references#CD006089-bbs2-0054" title="MorrisP , LeachA . Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001094.pub2] ">Morris 2002</a> reviewed studies on children. We limited the duration of symptoms to 30 days or less to exclude participants with subacute or chronic rhinosinusitis, where the infection was probably not the primary cause of inflammation (<a href="./references#CD006089-bbs2-0025" title="BachertC , HörmannK , MösgesR , RaspG , RiechelmannH , MüllerR , et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy2003;58(3):176‐91. ">Bachert 2003</a>). </p> </section> <section id="CD006089-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We included only RCTs that compared antibiotic therapy versus placebo or no treatment. We included trials that permitted concurrent use of other medications if participants were allowed equal access in both the antibiotic and placebo groups. </p> </section> <section id="CD006089-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD006089-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006089-list-0003"> <li> <p>Cure in people with:</p> <ol id="CD006089-list-0004"> <li> <p>clinically diagnosed rhinosinusitis;</p> </li> <li> <p>rhinosinusitis confirmed by imaging.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD006089-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006089-list-0005"> <li> <p>Ratings of measures of overall well‐being.</p> </li> <li> <p>Severity or duration of different clinical symptoms:</p> <ol id="CD006089-list-0006"> <li> <p>resolution of purulent secretion;</p> </li> <li> <p>resolution of pain;</p> </li> <li> <p>illness duration;</p> </li> <li> <p>restriction of daily activities.</p> </li> </ol> </li> <li> <p>Use of concomitant medications:</p> <ol id="CD006089-list-0007"> <li> <p>analgesics;</p> </li> <li> <p>nasal decongestants.</p> </li> </ol> </li> <li> <p>Side effects.</p> </li> <li> <p>Clinical failure.</p> </li> <li> <p>Serious adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD006089-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006089-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases up to 18 January 2018 for this update:</p> <p> <ol id="CD006089-list-0008"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 12), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, in the Cochrane Library using the strategy in <a href="./appendices#CD006089-sec-0124">Appendix 1</a>; </p> </li> <li> <p>MEDLINE via Ovid (from January 1950 to January 2018) using the strategy in <a href="./appendices#CD006089-sec-0124">Appendix 1</a>; and </p> </li> <li> <p>Embase via Elsevier (from January 1974 to January 2018) using the strategy in <a href="./appendices#CD006089-sec-0126">Appendix 2</a>. </p> </li> </ol> </p> <p>We searched the following trials registries on 18 January 2018:</p> <p> <ol id="CD006089-list-0009"> <li> <p>the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>) (<a href="./appendices#CD006089-sec-0127">Appendix 3</a>); and </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>) (<a href="./appendices#CD006089-sec-0128">Appendix 4</a>). </p> </li> </ol> </p> <p>We did not restrict the results by language or publication status.</p> </section> <section id="CD006089-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We scrutinised the reference lists of identified trials, systematic reviews, and relevant guidelines for other eligible trials. </p> </section> </section> <section id="CD006089-sec-0054"> <h3 class="title" id="CD006089-sec-0054">Data collection and analysis</h3> <section id="CD006089-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ML, ADS) independently screened titles and abstracts of all studies identified as a result of the search for studies that were potentially eligible for inclusion in the review. We retrieved the full‐text study reports, and two review authors (ML, ADS) independently screened the full texts to identify studies for inclusion, and identify and record reasons for exclusion of ineligible studies. Any disagreements were resolved through discussion or by consulting a third review author (MVD) where necessary. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and <a href="./references#CD006089-sec-0139" title="">Characteristics of excluded studies</a> table (<a href="./references#CD006089-bbs2-0053" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA Statement. BMJ2009;339:2535. ">Moher 2009</a>). We did not impose any language restrictions. </p> </section> <section id="CD006089-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form for study characteristics and outcome data that had been piloted on at least one study in the review. Two review authors (ML, ADS) extracted the following study characteristics from the included studies. </p> <p> <ol id="CD006089-list-0010"> <li> <p>Methods: study design, total duration of study, details of any 'run in' period, number of study centres and location, study setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: N, mean age, age range, gender, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, and excluded medications.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (ML, ADS) independently extracted outcome data from the included studies. We noted in the <a href="./references#CD006089-sec-0138" title="">Characteristics of included studies</a> table if outcome data were not reported in a usable way. There were no disagreements. One review author (ML) transferred data into the Review Manager 5 file (<a href="./references#CD006089-bbs2-0056" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. A second review author (ADS) spot‐checked study characteristics for accuracy against the trial report. </p> </section> <section id="CD006089-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ML, ADS) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006089-bbs2-0043" title="HigginsJP , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). Any disagreements were resolved by discussion. We assessed the risk of bias according to the following domains. </p> <p> <ol id="CD006089-list-0011"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ol> </p> <p>We graded each potential source of bias as high, low, or unclear and provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised the 'Risk of bias' judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes, where necessary. Where information on risk of bias related to unpublished data or correspondence with a trialist, we planned to note this in the 'Risk of bias' table. </p> <p>When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. </p> <section id="CD006089-sec-0058"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol and reported any deviations from it in the <a href="#CD006089-sec-0136">Differences between protocol and review</a> section. We ensured that current Cochrane methods were applied. </p> </section> </section> <section id="CD006089-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <p>We entered outcome data for each study into the data tables in Review Manager 5 to calculate the treatment effects (<a href="./references#CD006089-bbs2-0056" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used odds ratio for dichotomous outcomes, and mean differences or standardised mean differences for continuous outcomes. </p> <p>We conducted meta‐analyses only where this was meaningful, that is the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense. </p> </section> <section id="CD006089-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <p>In trials with multiple treatment groups, we compared event rates in the antibiotic treatment arms (intervention) with placebo event rates (control). We did not include cluster‐RCTs. </p> </section> <section id="CD006089-sec-0061"> <h4 class="title">Dealing with missing data</h4> <p>Where numerical outcome data were missing and could not be obtained from the authors, these were calculated from other available statistics, according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006089-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> </section> <section id="CD006089-sec-0062"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed variability among studies for statistical heterogeneity using Cochran's test for heterogeneity and the I² statistic. The I² statistic describes the percentage of variability in effect estimates that is due to heterogeneity rather than to sampling error. We considered a value greater than 50% to represent substantial heterogeneity, in which case we used a random‐effects model. </p> </section> <section id="CD006089-sec-0063"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to construct funnel plots to assess the likelihood of publication bias if 10 studies or more were available for analysis. </p> </section> <section id="CD006089-sec-0064"> <h4 class="title">Data synthesis</h4> <p>We pooled data from studies judged to be clinically homogeneous using Review Manager 5 software (<a href="./references#CD006089-bbs2-0056" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). If more than one study provided usable data in any single comparison, we performed a meta‐analysis. </p> <section id="CD006089-sec-0065"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>We created <a href="./full#CD006089-tbl-0001">summary of findings Table for the main comparison</a> using the following outcomes. </p> <p> <ol id="CD006089-list-0012"> <li> <p>Cure in adults with clinically diagnosed rhinosinusitis.</p> </li> <li> <p>Cure in adults with rhinosinusitis confirmed by radiography.</p> </li> <li> <p>Cure in adults with rhinosinusitis confirmed by CT scan.</p> </li> <li> <p>Resolution of purulent secretion.</p> </li> <li> <p>Side effects: general.</p> </li> <li> <p>Side effects: diarrhoea.</p> </li> <li> <p>Clinical failure<i>.</i> </p> </li> </ol> </p> <p>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contributed data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD006089-bbs2-0022" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006089-bbs2-0044" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>),using GRADEpro GDT software (<a href="./references#CD006089-bbs2-0036" title="McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT. Version (accessed prior to 10 May 2018). Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.), 2015. ">GRADEpro GDT 2015</a>). We justified all decisions to down‐ or upgrade the quality of studies using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> <section id="CD006089-sec-0066"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses.</p> <p> <ol id="CD006089-list-0013"> <li> <p>Clinically diagnosed rhinosinusitis.</p> </li> <li> <p>Rhinosinusitis confirmed by imaging.</p> </li> </ol> </p> <p>We used the Chi² test to test for subgroup interactions using Review Manager 5 software (<a href="./references#CD006089-bbs2-0056" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD006089-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out the following sensitivity analyses.</p> <p> <ol id="CD006089-list-0014"> <li> <p>Excluding studies at higher risk of bias.</p> </li> <li> <p>Assessing the influence of missing data: adding dropouts as failures, successes or as having the same cure rate as control group. </p> </li> <li> <p>Adding participants who were 'improved' to those who were cured.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006089-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006089-sec-0068"></div> <section id="CD006089-sec-0069"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD006089-sec-0138" title="">Characteristics of included studies</a> and <a href="./references#CD006089-sec-0139" title="">Characteristics of excluded studies</a> tables. </p> <section id="CD006089-sec-0070"> <h4 class="title">Results of the search</h4> <p>For the 2018 update, after deleting duplicates, we identified 524 new records from electronic searches. We rejected 354 records on the basis of title or keyword assessment, 52 records after assessing abstracts, and three records following full‐text record assessment. We rejected 115 trials based on information from trials registers (WHO ICTRP or ClinicalTrials.gov). No new studies were added for this update as a result of 2018 searches (<a href="#CD006089-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006089-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006089-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006089-sec-0071"> <h4 class="title">Included studies</h4> <p>Because we merged two Cochrane Reviews (<a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a>; <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>), we revised search results from <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a>, and included five studies (631 participants) from <a href="./references#CD006089-bbs2-0067" title="Ahovuo‐SalorantaA , RautakorpiUM , BorisenkoOV , LiiraH , WilliamsJWJr , MäkeläM . Antibiotics for acute maxillary sinusitis in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD000243.pub3] ">Ahovuo‐Saloranta 2014</a> (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0060" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJJ , PeetersMF . No benefit of antibiotic treatment in acute maxillary sinusitis: a randomized double‐blind placebo‐controlled study. Nederlands Tijdschrift voor Geneeskunde1997;141(49):2405‐11. ">Van Buchem 1997b</a>). (<a href="./references#CD006089-bbs2-0060" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJJ , PeetersMF . No benefit of antibiotic treatment in acute maxillary sinusitis: a randomized double‐blind placebo‐controlled study. Nederlands Tijdschrift voor Geneeskunde1997;141(49):2405‐11. ">Van Buchem 1997b</a> was a Dutch translation of <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; we used data from <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). We retained 10 trials (2450 participants) that were included in <a href="./references#CD006089-bbs2-0069" title="DeSutterAIM , LemiengreMB , MerensteinD , YoungJ , vanDrielML . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD006089.pub3] ">De Sutter 2012</a> (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> <p>We included 15 trials involving a total of 3057 participants for this update.</p> <section id="CD006089-sec-0072"> <h5 class="title">Design</h5> <p>With one exception, all included trials were randomised controlled trials (RCTs) that compared an antibiotic with a placebo. <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> (most probably) compared antibiotic treatment to no treatment. </p> </section> <section id="CD006089-sec-0073"> <h5 class="title">Sample sizes</h5> <p>Ten trials involving 2450 participants concerned clinically diagnosed rhinosinusitis (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> <p>Five trials involving 631 participants concerned rhinosinusitis confirmed by imaging (radiology investigation: 431 participants (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>); CT scan: 200 participants (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>)). In addition, <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> identified a subgroup of 82 participants in which rhinosinusitis was confirmed by radiography. </p> </section> <section id="CD006089-sec-0074"> <h5 class="title">Setting</h5> <p>Eleven trials recruited participants from ambulatory care settings (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). One trial also enrolled walk‐in and non‐referred participants from otolaryngology outpatient clinics of the university hospital (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>). <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> recruited participants from an outpatient clinic of a university hospital. <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> enrolled participants from 14 medical centres worldwide, but settings were not described. <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> and <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> did not describe study settings. </p> </section> <section id="CD006089-sec-0075"> <h5 class="title">Participants</h5> <section id="CD006089-sec-0076"> <h6 class="title">Inclusion criteria</h6> <p>All included studies used clinical signs and symptoms to enrol participants. The three most common inclusion criteria were nasal discharge (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), facial pain (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and common cold or upper respiratory tract infection (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). Two studies included participants with pus in the nasal cavity on rhinoscopy (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>), but this symptom was a clinical criterion for inclusion in three trials (<a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> <p>Five studies used imaging criteria to include participants: confirmed secretion on radiography (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>), homogenous shadows in the sinuses or a fluid level on radiography (<a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>), more than 5 mm mucosal thickening, opacity or fluid level on radiography (<a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>), presence of fluid level or total opacification in any sinus on CT (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>), and presence of mucosal thickening without fluid levels or total opacification on CT (<a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>). In these trials, participants were preselected on clinical suspicion of having sinusitis. No further details about the clinical criteria used to select participants were provided. <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> used the presence, in at least one sinus, of an air‐fluid level, a complete opacity, or a mucosal thickening of 10 mm as a criterion to identify participants for their subgroup of participants with radiologically confirmed maxillary sinusitis. </p> </section> <section id="CD006089-sec-0077"> <h6 class="title">Exclusion criteria</h6> <p>Common exclusion criteria were recent antibiotic use (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), severe illness (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>), symptoms of complicated rhinosinusitis (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), long‐lasting symptoms before inclusion (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), chronic ear, nose, and throat disease (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), comorbidity (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), previous sinus surgery (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), immune deficiency (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>), allergy for study medication (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), pregnancy or lactation (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and inability to follow the protocol (language or mental problems) (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). Due to the occurrence of a brain abscess in a placebo group participant, after 2000, <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a> excluded people with CRP levels greater than 100 mg/L or between 50 and 99 mg/L as a safety measure is there was clinical deterioration or CRP increase greater than 100 mg/L within three days of inclusion. No participants had to be excluded due to this new exclusion criterion. <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> excluded participants who were recently treated with nasal decongestants. <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> excluded participants with a positive pharyngeal culture for <i>Streptococcus pyogenes</i>. Lindbaek and colleagues excluded participants who misused alcohol or narcotics and those who had rheumatic disease (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>). <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> excluded participants who rated their symptoms as very mild or mild. <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> excluded participants who used xylometazoline nose drops for more than seven days, received antacid or iron treatment, or were referred to an ear, nose, and throat specialist. </p> </section> <section id="CD006089-sec-0078"> <h6 class="title">Characteristics of the participants</h6> <p>The average age of participants was approximately 36 years. <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> did not report participants' mean age, but we calculated a median age of between 30 and 39 years. <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>, <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>, and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> permitted younger participants, but the mean age of the study population was comparable to the average (33 years in <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>, 38.6 years in <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>, and 39.7 years in <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>). </p> <p>The male‐to‐female ratio was about 5:8.</p> <p>The mean duration of symptoms before inclusion was around or at least seven days in seven trials (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Participants had symptoms for about four to five days before inclusion in two trials (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>). The mean duration of symptoms at baseline was longer in two studies (11 days in <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> and 15.4 days in <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>, <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>, <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>, and <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a> did not report the mean duration of symptoms before inclusion. </p> </section> </section> <section id="CD006089-sec-0079"> <h5 class="title">Interventions</h5> <section id="CD006089-sec-0080"> <h6 class="title">Treatment group</h6> <p>Nine studies compared amoxicillin to placebo (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Of these nine studies, five had more than one treatment arm, and three compared several antibiotic courses to placebo (penicillin V and amoxicillin (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>); amoxicillin, penicillin V, and doxycycline (<a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>)). </p> <p>Two studies compared an antibiotic course and/or corticosteroid spray to placebo (<a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>) <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> compared mometasone furoate nasal spray once daily only, mometasone furoate nasal spray twice daily only, and amoxicillin only. <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> compared budesonide nasal spray only, amoxicillin only, budesonide nasal spray and amoxicillin. </p> <p><a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> compared pivampicillin to placebo; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> compared azithromycin to placebo; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> and <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> compared doxycycline to placebo; and <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a> compared amoxicillin/clavulanic acid to placebo. <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> compared irrigation, phenoxymethylpenicillin and lincomycin to no treatment. </p> <p>Treatment arms without antibiotic treatment were excluded from analyses (irrigation arm (44 participants) in <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; mometasone furoate nasal spray once daily only (243 participants), mometasone furoate nasal spray twice daily (235 participants) in <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>). </p> <p>All antibiotics were administered orally.</p> </section> <section id="CD006089-sec-0081"> <h6 class="title">Co‐interventions</h6> <p>Ten studies permitted nasal decongestants and analgesics (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> did not permit use of nasal decongestants. Six studies prescribed nasal decongestants for all participants (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). Two studies did not describe use of nasal decongestants (<a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Four studies did not describe use of analgesics (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). One study prescribed cough syrup (dextromethorphan hydrobromide or guaifenesin) for all participants (<a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>). </p> </section> </section> <section id="CD006089-sec-0082"> <h5 class="title">Outcomes</h5> <section id="CD006089-sec-0083"> <h6 class="title">Primary outcome: cure</h6> <p>Definitions of cure and time of evaluation varied among trials that used cure as primary outcome (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). This was reflected in variations in cure rates in placebo groups (clinical diagnosis: 30% to 74%; diagnosis confirmed by imaging: 11% to 59%). </p> <section id="CD006089-sec-0084"> <p><b>Clinically diagnosed rhinosinusitis</b></p> <p>Eight trials defined cure or improvement as primary outcome (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). The common denominator of all definitions was the resolution or improvement of major symptoms, evaluated only by the participant (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), or by the participant and the investigator (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). </p> <p>The two remaining trials used change on a symptom score as the main outcome measure: <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> used the mean change in Sino‐Nasal Outcome Test‐16 score, a validated and responsive measure, to assess the effect of treatment on disease‐specific quality of life at day 3, and <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> used the mean AM/PM major symptom score (sum of scores for rhinorrhoea, postnasal drip, nasal decongestion/stuffiness, sinus headache, and facial pain/pressure/tenderness on palpation over the paranasal sinuses) over days 2 to 15 of the treatment phase as a primary outcome measure. </p> </section> <section id="CD006089-sec-0085"> <p><b>Rhinosinusitis confirmed by imaging</b></p> <p>Six studies defined cure as primary outcome (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> (subgroup of participants with radiologically confirmed maxillary sinusitis); <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). The common denominator in all definitions was resolution or improvement of major symptoms, evaluated by the participant alone (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>), or by the participant and the investigator (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>). However, <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> evaluated sinus recovery rather than participants. </p> </section> </section> <section id="CD006089-sec-0086"> <h6 class="title">Secondary outcomes</h6> <p>Some trials provided information on effects on purulent secretion (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>), pain (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), malaise (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), illness duration (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), restriction of daily activities (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997;</a><a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), intake of analgesics (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), intake of nasal decongestants (<a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), side effects (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>), clinical failure (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and serious adverse events (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> <p>Seven studies collected laboratory samples (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). Four studies obtained nasopharyngeal secretions for culture (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> performed a sinus puncture. Two studies measured CRP, leukocytes and neutrophils (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). Only <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> reported interaction between culture result, cure and treatment group. <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> found that participants in the antibiotic group with positive culture had lower symptom scores (P = 0.002) and a higher rate of symptom resolution on day 7 (73% versus 47%; P = 0.007) and a higher cure rate on day 8 (65% versus 41%; P = 0.032) compared to placebo group participants. There was no significant difference in symptom resolution on day 7 in the culture‐negative group between antibiotic and placebo group participants (63% versus 69%; P = 0.75). </p> <p>See <a href="./references#CD006089-sec-0138" title="">Characteristics of included studies</a>. </p> </section> </section> </section> <section id="CD006089-sec-0087"> <h4 class="title">Excluded studies</h4> <p>We had previously excluded five studies. Three RCTs included participants with clinical symptoms of acute rhinosinusitis and specific bacteriological criteria (<a href="./references#CD006089-bbs2-0016" title="GanancaM , TrabulsiLR . The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo‐controlled study. Current Medical Research and Opinion1973;1(6):362‐8. ">Gananca 1973</a>; <a href="./references#CD006089-bbs2-0017" title="GanancaMM , GaselJJ . A double‐blind study with the association tetracycline, acetylsalicylic acid, phenacetin, caffeine and phenyltoloxamine in the treatment of acute sinusitis. Folha Medica1977;75(5):583‐5. ">Gananca 1977</a>; <a href="./references#CD006089-bbs2-0018" title="HadleyJA , MosgesR , DesrosiersM , HaverstockD , vanVeenhuyzenD , Herman‐GnjidicZ . Moxifloxacin five‐day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope2010;120(5):1057‐62. ">Hadley 2010</a>). One excluded study had included participants with clinical symptoms (maxillary pain) and raised values of either C‐reactive protein (CRP) or erythrocyte sedimentation rate (ESR) (<a href="./references#CD006089-bbs2-0019" title="HansenJG , SchmidtH , GrinstedP . Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care2000;18(1):44‐7. ">Hansen 2000a</a>; <a href="./references#CD006089-bbs2-0041" title="HansenJG , SchmidtH , GrinstedP . [Penicillin treatment of acute maxillary sinusitis in adults. A randomized, double‐blind, placebo‐controlled trial from general practice].. Ugeskr Laeger2000;162(40):5351‐3. ">Hanssen 2000b</a> was a Danish translation of <a href="./references#CD006089-bbs2-0019" title="HansenJG , SchmidtH , GrinstedP . Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care2000;18(1):44‐7. ">Hansen 2000a</a>). <a href="./references#CD006089-bbs2-0020" title="HayeR , LingaasE , HoivikHO , OdegardT . Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases1998;17(5):309‐12. ">Haye 1998</a> was excluded because participants with empyema (defined as complete opacity or an air‐fluid level, or a mucosal thickness of 6 mm or more measured at the upper lateral border of the maxillary sinus) were withheld. See <a href="./references#CD006089-sec-0139" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD006089-sec-0088"> <h3 class="title">Risk of bias in included studies</h3> <p>'Risk of bias' assessments are reported in <a href="./references#CD006089-sec-0138" title="">Characteristics of included studies</a> and graphically presented in <a href="#CD006089-fig-0002">Figure 2</a> and <a href="#CD006089-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006089-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006089-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006089-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006089-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006089-sec-0089"> <h4 class="title">Allocation</h4> <p>The risk of selection bias was low in nine studies (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and unclear in four studies (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). </p> <p>Ten studies reported adequate allocation sequencing (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Four studies used block randomisation (<a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>); two used unrestricted randomisation (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>); and four studies combined blocked and stratified randomisation (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>). Six studies used a computerised random number generator (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> used dice. <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> used random number tables to select the blocks. Four studies presented insufficient information about the sequence generation process to inform assessment (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> and <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> reported only random assignment. Two studies reported using a block randomisation procedure but did not specify the process to select blocks (<a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). </p> <p>Ten trials concealed allocation adequately (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Four trials did not provide information on methods used to blind participants and investigators enrolling participants (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). One study reported only that the medication boxes or envelopes were identical for drugs and placebo, but did not state use of sequential numbering (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>). </p> </section> <section id="CD006089-sec-0090"> <h4 class="title">Blinding</h4> <p>The risk of performance and detection bias was low in 12 studies (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), unclear in 2 studies (<a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>), and high in 1 study (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>). </p> <p>Eleven trials blinded allocated intervention adequately (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). The intervention and placebo tablets were identical in colour, shape, and taste, and blinding of participants and investigators was assured in these studies. Two studies indicated double‐blinding, but did not provide information about the blinding procedure (<a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>). <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> did not provide precise information on how the randomisation result was concealed, but the method of random sequence generation (computer‐randomised code) and information on double‐dummy design gave the impression that concealment had been fulfilled (additional information requested but not received from the trial authors). <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> did not mention blinding in the methods section, and close examination of the study design led us to strongly believe that there was no blinding: placebo group participants did not take tablets, only nose drops; it is not possible to blind sinus irrigation as an intervention; only group 1 participants received radiological evaluation every second day; and group 2 participants took a longer course of tablets than group 3. We therefore graded the risk of bias for this domain as high for <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>. </p> </section> <section id="CD006089-sec-0091"> <h4 class="title">Incomplete outcome data</h4> <p>The risk of attrition bias was low in 13 studies (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and unclear in 2 studies (<a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>). </p> <p>The overall post‐randomisation dropout rate was 5.1%. <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> did not report post‐randomisation dropout rates. </p> <p>The ratio of participants with missing data to participants with events is a good marker of bias due to incomplete data (<a href="./references#CD006089-bbs2-0043" title="HigginsJP , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). In the 13 included studies with cure as the primary outcome, the ratio ranged from 0.01 to 0.33 (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). However, the ratio was low (0.09) for <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>, who reported "significant improvement at day 10." The risk of bias due to dropout was low in these 13 studies. We could not calculate the ratio of participants with missing data to participants with events for <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>, because the primary outcome was not cure, but a difference in symptom scores. However, the post‐randomisation dropout rate was low (2.6% at day 15) in <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> and probably did not cause bias. </p> <p>Two studies performed sensitivity analyses. In <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a> and <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>, different scenarios did not reveal a significant difference in cure rate between the intervention and control group. <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> conducted a sensitivity analysis for participants who completed the study drug and those with symptoms for seven days or more and 28 days or less. <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a> imputed dropouts as treatment failures. </p> <p>Ten studies followed the intention‐to‐treat (ITT) principle for analysis of the main outcome (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). Four trials included only participants with complete outcome data (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> </section> <section id="CD006089-sec-0092"> <h4 class="title">Selective reporting</h4> <p>The risk of reporting bias was low in 12 studies (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and unclear in 3 studies (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>). </p> <p>Twelve studies predefined primary and secondary endpoints (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Definitions of primary outcomes were unclear in two studies (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>). <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> predefined symptoms, side effects, and medication intake that were to be recorded, but provided the definition of cure for the first time in the results section of the report. <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> reported most outcomes of interest incompletely; data could not be pooled with other trials. <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> performed an individual participant data meta‐analysis and had the results of an unpublished Schering‐Plough trial. This trial had the same design as <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>, but had a lower odds ratio. This could suggest selective reporting in <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>. </p> </section> <section id="CD006089-sec-0093"> <h4 class="title">Other potential sources of bias</h4> <p>The risk of other potential sources of bias was low in 12 studies (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and unclear in 3 studies (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). </p> <p>No included studies contained design‐specific risks of bias or were stopped early. Two studies had small, unimportant imbalances of baseline participant characteristics (<a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> did not describe participants' characteristics at baseline, and <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> provided only limited information about these characteristics. One blinded trial broke blinding 12 times due to side effects (3 participants) or clinical failure (9 participants) (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>). Following the ITT principle, these participants were included in the analyses in the groups to which they were originally randomised (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>). <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> possibly selected participants with worse symptoms, since only 20% of participants with possible maxillary sinusitis entered the trial. </p> <p>Study protocols for participants in intervention and placebo groups were similar. There was a low risk of bias due to increased or different diagnostic activity. </p> <p>Seven studies were financially supported by government or academic institutions (<a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Researchers in six studies received grants from pharmaceutical industry sources (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997;</a><a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Five studies did not state sources of support (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). </p> <p>More than 276 practices recruited participants. Two trials recruited participants from one site (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>). Eight trials recruited participants from multiple sites, with an average of 9.9 participants per practice (range 3.6 to 15.8, 25th percentile = 6.5, 75th percentile = 15.5) (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). The number of participating practices was not reported in five trials (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). </p> </section> </section> <section id="CD006089-sec-0094"> <h3 class="title" id="CD006089-sec-0094">Effects of interventions</h3> <p>See: <a href="./full#CD006089-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotics compared to placebo for acute rhinosinusitis in adults</a> </p> <section id="CD006089-sec-0095"> <h4 class="title">Primary outcome</h4> <section id="CD006089-sec-0096"> <h5 class="title">1. Cure</h5> <p>Without antibiotics, 46% of participants with rhinosinusitis, whether or not confirmed by radiography, were cured after one week (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and 64% after 14 days (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). </p> <section id="CD006089-sec-0097"> <h6 class="title">1.1 Clinically diagnosed rhinosinusitis</h6> <p>The ITT population included 2450 participants (10 trials). We analysed data from 1687 participants (69%). We excluded <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> (499 participants) and <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> (166 participants) because the proportion of participants cured at a specific time point was not reported as cure was not their main outcome measure. <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> reported only the total cure rate for both groups and stated there was no difference between groups. We used the same percentages in both groups for pooling. </p> <p>Despite choices made by some trial authors, we considered participants who started other antibiotics as treatment failures, not dropouts. The total dropout rate was 5.3%. </p> <p>Almost half (47%) of participants were cured after one week (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), 51% after 10 days (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), and 71% after 14 days (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>), irrespective of treatment group. </p> <p>The estimated odds ratio (OR) for the overall treatment effect of antibiotics relative to placebo was 1.25 (95% confidence interval (CI) 1.02 to 1.54; number needed to treat for an additional beneficial outcome (NNTB) 19, 95% CI 10 to 205; I² = 0%; high‐quality evidence; <a href="./references#CD006089-fig-0007" title="">Analysis 1.1</a>.1; <a href="#CD006089-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD006089-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Antibiotics versus placebo in acute rhinosinusitis, outcome: 1.1 Cure." data-id="CD006089-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antibiotics versus placebo in acute rhinosinusitis, outcome: 1.1 Cure. </p> </div> </div> </div> <p>We categorised studies into three groups: cure assessed at one week (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>); cure assessed at around day 10 (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>); and cure assessed at day 14 (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Heterogeneity among studies was very low (0% at 1 week and 10 days; 6% at 14 days). </p> <p>There were no significant differences between treatment groups: after one week, the OR for cure was 1.07 (95% CI 0.81 to 1.41; <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.1); after 10 days OR for cure was 1.19 (95% CI 0.92 to 1.53; <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.2); and after 14 days OR for cure was 1.37 (95% CI 0.98 to 1.91; <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.3). <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> did not find any difference in symptom score between the antibiotic and placebo groups at day 15, so we assumed that adding data from this study would not change our overall result. <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> found a significant difference in symptom score at day 7, favouring amoxicillin (mean difference (MD) 0.19, 95% CI 0.02 to 0.35). This study also provided data about "significantly improved" participants. Including these data (<a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.4 and <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.5) did not substantially change the overall result. </p> <p>We used three methods to impute data to assess the influence of missing data on the overall results: assuming the outcomes of participants for whom no outcome was recorded as cured; not cured; or according to the cure rate observed in the control group. Twelve analyses revealed no clear differences for the baseline analyses (<a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.6 to <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.17). </p> <p>Excluding studies that included ITT analyses removed antibiotic benefit (OR 1.06, 95% CI 0.76 to 1.47) (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). Pooling studies with ITT analyses confirmed benefit of antibiotics (OR 1.39, 95% CI 1.07 to 1.79). </p> <p>Pooling studies in which participants declared themselves as cured endorsed the benefit of antibiotics (OR 1.40, 95% CI 1.08 to 1.82) (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Pooling studies in which the investigator decided if the participant was cured showed no benefit of antibiotics (OR 1.05, 95% CI 0.76 to 1.46) (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). </p> <p>Studies that included only participants with pus on rhinoscopy revealed no benefits with antibiotics (OR 1.07, 95% CI 0.74 to 1.56) (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>). </p> </section> <section id="CD006089-sec-0098"> <h6 class="title">1.2 Rhinosinusitis confirmed by imaging</h6> <p>The ITT population included 713 participants, and we analysed data from 652 participants (91.4%). We excluded 61 participants from the <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> study because the primary outcome was sinus recovery progress instead of cure. </p> <p>Four trials included participants on the basis of clinical signs and symptoms (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>); radiographs were taken, but only one study used images to assess cure rates (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>). All participants underwent sinus ultrasound in <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>. The impact of ultrasound result cure rates was not reported. </p> <p>We considered participants who started other antibiotics as treatment failures, not dropouts. The total dropout rate was 4.3%. <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> did not report post‐randomisation dropout rates. </p> <p>Cure was evaluated at day 8 (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>), day 10 (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>), or day 14 (<a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). The estimated OR for the overall treatment effect of antibiotics relative to placebo was 1.71 (95% CI 1.20 to 2.45; NNTB 8, 95% CI 5 to 23; I² = 41%; <a href="./references#CD006089-fig-0013" title="">Analysis 3.2</a>.1). Heterogeneity was high, so we looked for outliers and split analyses for participants with rhinosinusitis confirmed by radiography or CT. </p> <p>However, treatment effects among those who underwent CT differed significantly from effects in participants selected by radiography. Pooling these data was therefore not possible, and analyses were performed separately. </p> <p>Three studies used radiography to confirm maxillary sinusitis (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). The estimated OR was 1.57 (95% CI 1.03 to 2.39; NNTB 10, 95% CI 5 to 136; I² = 0%; moderate‐quality evidence; <a href="./references#CD006089-fig-0007" title="">Analysis 1.1</a>.2; <a href="#CD006089-fig-0004">Figure 4</a>). Omitting <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>, which was assessed as at high risk of bias due to lack of blinding, did not have a significant impact on this result (OR 1.67, 95% CI 1.04 to 2.70, NNBT 9, 95%CI 5 to 104). </p> <p><a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> reported on two distinct participant groups who underwent CT examination: those with fluid level or total opacification in any sinus on CT, and those with mucosal thickening on CT. The effect of antibiotics relative to placebo was only significant in the group with fluid level or total opacification in any sinus on CT (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>: estimated OR 4.89, 95% CI 1.75 to 13.72; NNTB 4, 95% CI 2 to 15; moderate‐quality evidence; <a href="./references#CD006089-fig-0007" title="">Analysis 1.1</a>.3; <a href="#CD006089-fig-0004">Figure 4</a>; ) (<a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>: estimated OR 0.74, 95% CI 0.25 to 2.16). </p> <p>Four studies reported on cure or improvement (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). The estimated OR for overall treatment effect of antibiotics relative to placebo was 2.08 (95% CI 1.35 to 3.21; NNTB 8, 95% CI 6 to 18; I² = 33%; <a href="./references#CD006089-fig-0013" title="">Analysis 3.2</a>.2). Heterogeneity was high. Studies that used radiography to confirm maxillary sinusitis indicated no difference in improvement rates between participants who received antibiotics versus those who received placebo (estimated OR 1.59, 95% CI 0.90 to 2.80; I² = 0%, NNTB 9, 95% CI 5 to 40) (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). The effect of antibiotics relative to placebo on 'improvement' was significant only in participants with fluid level or total opacification in any sinus on CT (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>: estimated OR 4.5, 95% CI 1.91 to 10.57; NNTB 4, 95% CI 3 to 7) (<a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>: estimated OR 1.60, 95% CI 0.51 to 5.06). </p> </section> </section> </section> <section id="CD006089-sec-0099"> <h4 class="title">Secondary outcomes</h4> <section id="CD006089-sec-0100"> <h5 class="title">1. Ratings of measures of overall well‐being</h5> <p>Three studies investigated whether participants' general feeling of illness improved faster with antibiotics (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). It was not possible to pool data for meta‐analysis because <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a> used data from a diary, <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a> compared Likert scores at different time points, and <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> looked at differences in symptom scores for "sickness" after one and two weeks. Only <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> found a marginal but significant difference in symptom score for sickness after two weeks evaluated by the investigator (mean change 1.2 for placebo versus 0.8 for antibiotics, "P &lt; 0.05" reported by <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). This finding did not persist when the degree of sickness was evaluated by the participant. </p> <p><a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> found no significant interaction between baseline severity (feeling unwell and level of daily activity restriction) and treatment group (antibiotic versus placebo). </p> </section> <section id="CD006089-sec-0101"> <h5 class="title">2. Severity or duration of different clinical symptoms</h5> <section id="CD006089-sec-0102"> <h6 class="title">2.1. Resolution of purulent secretion</h6> <p>Five studies reported outcome data for purulent secretion (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). We extracted data from one study on day 8 (<a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>), and two studies on day 10 (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a> provided data upon request. <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> published only least‐square means data. Outcomes were reported by participants in two studies (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>), the investigator in two studies (<a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>), and by both participants and investigators in one study (<a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). </p> <p>The estimated OR for resolution of purulent secretion was 1.58, irrespective of endpoint timing (95% CI 1.13 to 2.22; NNTB 10, 95% CI 6 to 35; I² = 0%; high‐quality evidence; <a href="./references#CD006089-fig-0008" title="">Analysis 2.1</a>). </p> <p>We could not pool some data on purulent secretion. <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> found that 75% of participants in the antibiotic group and 56% in the placebo group had at least 50% reduction in secretion on day 8 (OR 2.29, 95% CI 1.11 to 4.74; NNTB 6, 95% CI 4 to 40; P = 0.002). Furthermore, <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a> found a significant mean change in mean score on the symptom "thick nasal discharge" between baseline and 10‐day follow‐up (P ≤ 0.001). These results were confirmed by <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>, who found a significant difference in least‐square means for rhinorrhoea between days 2 and 15 (P ≤ 0.01). <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> found a significant difference in symptom score for secretion at the right side after one week (reported by the participant) (mean change 1.0 for placebo versus 1.2 for antibiotics, "P &lt; 0.05" reported by <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>), but this difference disappeared after two weeks. Evaluation of secretion at clinical examination did not confirm this finding. </p> </section> <section id="CD006089-sec-0103"> <h6 class="title">2.2. Resolution of pain</h6> <p>Five studies provided outcome data for pain (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Unfortunately, as the outcome measures were too different and raw data were not available, pooling of data was not possible. </p> <p>Considering pain in general, no study found a difference in pain duration between the antibiotic and placebo groups (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). Full resolution of pain occurred between day 4 and day 7 in most participants. Also, when considering specific types of pain such as unilateral facial pain (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>), pain on bending forward (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>), pain in upper teeth or when chewing (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>), facial pain, pressure, or tenderness (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>), and sinus headache (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>), none of the trials detected a significant difference in pain duration when comparing antibiotic and placebo groups. Evaluating differences in symptom scores, <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> found no differences after one and two weeks for frontal pain, maxillary pain, headache on bending, or tapping pain. </p> </section> <section id="CD006089-sec-0104"> <h6 class="title">2.3. Illness duration</h6> <p>Five studies calculated the mean illness duration (<a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). All studies compared illness duration between antibiotic and placebo groups. We could not pool the data because the standard deviations were not available. <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a> reported the mean illness duration for participants with or without <i>Streptococcus pneumoniae</i> ,<i>Haemophilus influenzae</i> , or<i>Moraxella catarrhalis</i> in their nasopharyngeal secretions (with bacteria: five days in the azithromycin group versus seven days in the placebo group; without bacteria: six days in the azithromycin group versus six days in the placebo group), but not for the total group. <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> found a subjective improvement after an average of 3.5 days in the antibiotic group compared with 3.7 days in the placebo group. They did not mention if this was a significant difference, but we can assume that it was not. <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a> also did not find a significant difference: the mean illness duration in participants taking antibiotics was 6.0 days, compared with 6.4 days in the placebo group (P = 0.66). <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> found that participants with a fluid level or total opacification in any sinus on CT were cured seven days faster with antibiotic treatment than without (median time of the sinusitis episode: nine days in the amoxicillin group, 11 days in the penicillin group, and 17 days in the placebo group). Participants with only mucosal thickening on CT showed no significant difference in illness duration across the intervention groups (median time of the sinusitis episode: 10 days in the placebo and amoxicillin groups and 13.5 days in the placebo group) (<a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>). </p> </section> <section id="CD006089-sec-0105"> <h6 class="title">2.4. Restriction of daily activities</h6> <p>Four studies collected data on the restriction of daily activities due to rhinosinusitis (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). Pooling of data was not possible because the outcome measures were too different. None of the studies found a significant difference in activity restriction between the antibiotic and placebo groups. </p> <p><a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> found no significant interaction between baseline severity (feeling unwell and level of restriction on daily activity) and treatment group (antibiotic versus placebo). </p> </section> </section> <section id="CD006089-sec-0106"> <h5 class="title">3. Use of concomitant medications</h5> <section id="CD006089-sec-0107"> <h6 class="title">3.1. Analgesics</h6> <p>Ten studies allowed the use of analgesics, that is paracetamol, in <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>, <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>, <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>, <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>, <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>, <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>, <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>, <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>, and <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>, and/or ibuprofen, in <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>, <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>, <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>, and <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>. Five of these studies also recorded the use of analgesics (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). It was not possible to pool the data because the raw data were not available or the outcome measures were too different. There was no effect of antibiotics on the use of analgesics in four studies (<a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>). <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a> revealed that participants receiving placebo used analgesics more often than those receiving antibiotics (43% in the placebo group and 26% in the antibiotic group, P = 0.03). </p> </section> <section id="CD006089-sec-0108"> <h6 class="title">3.2. Nasal decongestants</h6> <p>Eleven studies allowed the use of xylometazoline nose drops (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). Six studies prescribed nasal decongestants for every participant (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> permitted the use of pseudoephedrine‐sustained action. <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a> did not mention if nose drops were permitted. Corticosteroid nose drops were part of the intervention in two studies (<a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> explicitly stated that use of concomitant medication that could interfere with the study medication was not permitted. </p> <p>Only two studies registered intake of nose drops (vasoconstrictors), <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> and <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>, and antihistamines, <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>. Pooling of data was not possible because the outcome measures were too dissimilar. Neither study found a significant difference between groups in use of these medications. <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> found no difference between groups in use of pseudoephedrine‐sustained action. </p> </section> </section> <section id="CD006089-sec-0109"> <h5 class="title">4. Side effects</h5> <p>The side effects described in the trials were nausea, vomiting, abdominal pain, stomach pain, diarrhoea, skin rash, dizziness, fatigue, hot flushes, jittery feeling, dry mouth, headache, epistaxis, and vaginal discharge or pruritus. The most common side effects were gastrointestinal. </p> <p>We pooled data from 10 trials on side effects in general (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a> reported only data about diarrhoea. We did not add data from <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> because the only side effects reported in this study were those that caused participants to stop their study medication. Of the participants who experienced side effects, 68.3% received antibiotics. This difference was statistically significant (OR 2.21, 95% CI 1.74 to 2.82; number needed to treat for an additional harmful outcome (NNTH) 8, 95% CI 6 to 12; I² = 16%; high‐quality evidence; <a href="./references#CD006089-fig-0009" title="">Analysis 2.2</a>; <a href="#CD006089-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD006089-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis whether or not confirmed by imaging, outcome: 2.2 Side effects: general." data-id="CD006089-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis whether or not confirmed by imaging, outcome: 2.2 Side effects: general. </p> </div> </div> </div> <p>More specifically, we could pool data on diarrhoea from seven trials (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> reported only the percentage of diarrhoea for both groups and stated there was no difference between groups. We used the same percentages in both groups for pooling. </p> <p>Of participants who received antibiotics, 16.7% reported diarrhoea, versus 9.6% of participants who received placebo. This result was statistically significant (Peto OR 2.00, 95% CI 1.41 to 2.85); NNTH 13, 95% CI 8 to 29; I² = 20%; high‐quality evidence; <a href="./references#CD006089-fig-0010" title="">Analysis 2.3</a>). We could not pool the results of <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a> because the raw data were not available, but their results were consistent with ours (OR 3.89, 95% CI 2.09 to 7.25 at day 7; OR 1.71, 95% CI 0.91 to 3.23 at 14 days). </p> <p><a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> only mentioned that there were no differences in treatment‐emergent side effects among the treatment groups. In that trial, five participants in the amoxicillin group and six in the placebo group discontinued treatment because of side effects. <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> and <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a> did not provide any information for this outcome. </p> </section> <section id="CD006089-sec-0110"> <h5 class="title">5. Clinical failure</h5> <p>We pooled data on clinical failure from 12 trials (<a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>; <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>; <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a>). In eight trials, clinical failure was assessed as an abnormal course of rhinosinusitis (exacerbation, ongoing symptoms, respiratory complications, treatment failure) leading to commence or extend antibiotic therapy. The number of treatment failures in the control and active treatment groups were compared (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>; <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>; <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>; <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>; <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a>). <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> reported numbers of participants who deteriorated at day 5 and 10. <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> and <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> reported numbers of participants who met the criteria for treatment failure, but did not report whether these were prescribed open antibiotic therapy. <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> reported the number of participants that withdrew because of treatment failure. </p> <p>The pooled result showed that clinical failure occurred less frequently in participants receiving antibiotics compared to placebo (6.1% versus 11.2%, Peto OR 0.48, 95% CI 0.36 to 0.63; NNTH 19, 95% CI 15 to 27; I² = 21%; high‐quality evidence; <a href="./references#CD006089-fig-0011" title="">Analysis 2.4</a>; <a href="#CD006089-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD006089-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, outcome: 2.4 Clinical failure." data-id="CD006089-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, outcome: 2.4 Clinical failure. </p> </div> </div> </div> </section> <section id="CD006089-sec-0111"> <h5 class="title">6. Serious adverse events</h5> <p>Only one serious disease‐related adverse event occurred in the placebo group (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>): after two weeks of symptomatic treatment, a participant who was treated for one week with amoxicillin‐clavulanate (1 g twice daily, open antibiotic therapy) experienced a brain abscess caused by an amoxicillin‐clavulanate‐sensitive strain of <i>Streptococcus milleri</i>. The participant was operated on and recovered but was reported to have a residual frontal syndrome. </p> <p>There were two additional serious adverse events in the placebo group: one myocardial infarction and one severe depressive episode (<a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>). Both were thought to be neither disease nor drug related. Other trials did not report any serious adverse events, which means that serious complications in participants with clinically diagnosed acute rhinosinusitis are rare. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006089-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006089-sec-0112"></div> <section id="CD006089-sec-0113"> <h3 class="title" id="CD006089-sec-0113">Summary of main results</h3> <p>The intention‐to‐treat (ITT) population included 3057 participants (15 trials). Without treatment, almost half of participants with acute rhinosinusitis, whether or not confirmed by radiography, recovered within one week, and two of three participants within 14 days. Antibiotics may slightly shorten the time to cure, but only 5 (diagnosis based on symptoms, range 1 to 10) to 11 (diagnosis confirmed by x‐ray, range 1 to 21) more participants per 100 would achieve cure faster by taking antibiotics instead of placebo. When a fluid level or total opacification was present on computed tomography (CT), 28 more participants per 100 (range 7 to 53) achieved cure faster with antibiotics. Antibiotics do not reduce the time to pain relief or the general feeling of illness. People who take antibiotics do not resume daily activities earlier and do not take less analgesics or nasal decongestants than people treated with placebo. In people with purulent rhinorrhoea, 10 more people per 100 (range 3 to 17) would experience a faster resolution of nasal discharge by taking antibiotics. However, we found that 13 more people per 100 (range 9 to 18) would experience side effects of the treatment. This potential harm needs to be compared to the possible benefit of people with purulent rhinorrhoea taking antibiotics. Five fewer people per 100 (range 3 to 7) would experience clinical failure if they took antibiotics instead of placebo (<a href="./full#CD006089-tbl-0001">summary of findings Table for the main comparison</a>). This review did not investigate the effect of antibiotics in people with proven positive bacterial sinus cultures. </p> </section> <section id="CD006089-sec-0114"> <h3 class="title" id="CD006089-sec-0114">Overall completeness and applicability of evidence</h3> <p>We investigated if antibiotic therapy could speed up the recovery process in people with acute rhinosinusitis, whether clinically diagnosed or confirmed by imaging. The main symptoms used for participant inclusion among the included studies were the presence of nasal discharge, facial pain, and a common cold or upper respiratory tract infection. This is in line with the clinical presentation of rhinosinusitis in patients in ambulatory care settings. We included studies where participant inclusion depended on clinical symptoms and abnormalities on radiography or CT. The reason for this was that in some countries, imaging is used to confirm diagnosis of rhinosinusitis. Based on included study populations, we are reasonably confident that this review covers the general population of people with rhinosinusitis‐like symptoms. We could draw no conclusions about the efficacy of antibiotics in children, people with suppressed immune systems, or those with serious diseases (e.g. very high fever, prolonged symptoms, septic symptoms such as tachycardia, sweating, and low blood pressure) and people referred to an ear, nose, and throat specialist because of the serious course of the disease or fear of complications, since trials did not include these groups of patients, and it is unlikely that they will be included in future placebo‐controlled trials. </p> </section> <section id="CD006089-sec-0115"> <h3 class="title" id="CD006089-sec-0115">Quality of the evidence</h3> <p>We used <a href="./references#CD006089-bbs2-0036" title="McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT. Version (accessed prior to 10 May 2018). Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.), 2015. ">GRADEpro GDT 2015</a> to assess evidence quality for each outcome (<a href="./full#CD006089-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We assessed high‐quality evidence for the following outcomes: cure in adults with clinically diagnosed acute rhinosinusitis; severity or duration of different clinical symptoms ‐ resolution of purulent secretion; general side effects; side effects relating to diarrhoea; and clinical failure. We assessed moderate‐quality evidence for cure in adults with acute rhinosinusitis confirmed by radiography, downgrading the quality of the evidence due to few trials reporting this outcome (n = 3) and wide confidence intervals. It is unlikely that participants in <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> were blinded: the study report not provide any information about blinding and give the study design, it is highly likely that "treatment" was compared to "no treatment". Therefore we assessed this study as at high risk of bias for this domain. Nevertheless, omitting the results of <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a> did not substantially changed the odds ratios (OR 1.67, 95% CI 1.04 to 2.70, NNTB 9, 95%CI 5 to 104)<i>.</i> For this reason, we did not further downgrade evidence quality for this outcome. </p> <p>Only one study with few participants (N = 127) reported cure in adults with acute rhinosinusitis confirmed by CT (<a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>). Although this was a robust trial, we downgraded the quality of the evidence to moderate because of the limited number of participants. </p> <p>All but three included studies reported on the main review outcome of rhinosinusitis cure (<a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>). The analyses show a consistent result. </p> </section> <section id="CD006089-sec-0116"> <h3 class="title" id="CD006089-sec-0116">Potential biases in the review process</h3> <p>We carried out thorough searches in several different databases on 18 January 2018. We used a predefined selection procedure for including and excluding studies and followed this strategy consistently. We documented reasons for exclusion. We predefined the research questions and answered them in the same sequence. </p> <p>We assessed the included studies and summarised information in the <a href="./references#CD006089-sec-0138" title="">Characteristics of included studies</a> table. We assessed risk of bias rigorously. It is possible we evaluated three studies as poor undeservedly, but this does not mean that the studies were performed incorrectly (<a href="./references#CD006089-bbs2-0011" title="RantanenT , ArvilommiH . Double‐blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngologica1973;76(1):58‐62. ">Rantanen 1973</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>); rather, we evaluated them as unclear risk of bias due to insufficient information reported in the articles. </p> <p>Some studies did not report raw data. In such cases, we estimated numbers of events by multiplying the percentage with the total number of participants in the group to make pooling of results possible. <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> reported only the total cure rate for both groups and stated there was no difference between groups. We used the same percentages in both groups for pooling. This assumption could be imprecise; however, omitting these data did not substantially change odds ratios. <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> performed a meta‐analysis on clinically diagnosed acute rhinosinusitis using individual patient data meta‐analysis (IPDMA). <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> had raw data from <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a> at his disposal, and reported that the exact cure rate was 63% in the placebo group and 66% in the antibiotic group when the primary outcome was assessed. Using these cure rates in our analysis did not substantially change odds ratios (OR 1.27, 95% CI 1.04 to 1.56; number needed to treat for an additional beneficial outcome (NNTB) 18, 95% CI 10 to 104; <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.18). <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> reported only the percentage of diarrhoea for both groups and stated there was no difference between groups. We used the same percentages in both groups for pooling. Omitting these data from the analyses did not substantially change the odds ratios (OR 2.19, 95% CI 1.51 to 3.18; NNTB 11, 95% CI 7 to 24). </p> <p>Definitions of cure varied among trials, and this raised questions about the comparability of studies; however, the underlying interpretation of cure was similar. As well as calculating the overall treatment effect, we divided the studies into three groups (cure at one week, 10 days, and 14 days) to assess the effect at various time points. </p> <p>For the primary outcome of cure, we checked if inputting missing data in three different ways changed the overall result (<a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.6 to <a href="./references#CD006089-fig-0012" title="">Analysis 3.1</a>.17). </p> <p>For the secondary outcome, resolution of purulent secretion, data were collected once by the participant, and once by the clinician (inspection). Due to the low number of studies, we did not take this into account. </p> <p>There was important variation in choices of antibiotics and dosage schedules. This may be due to differences in antibiotic resistance at different time points and in different countries. We assumed that the trial authors' choice of antibiotics was suitable for their countries and local resistance patterns at that point in time, and that this did not influence the effect of the antibiotic treatment on cure rates. However, since the trials did not perform bacterial cultures, we cannot prove this. </p> <p>As we considered only studies that included adults without bacteriological cultures, the proportion of adults with bacterial rhinosinusitis is unknown. However, as described, we wanted to focus on adults who visited general practitioners with acute rhinosinusitis symptoms and who are treated empirically, with or without imaging. This review answers the important clinical question of whether these people should be treated with antibiotics or not. </p> </section> <section id="CD006089-sec-0117"> <h3 class="title" id="CD006089-sec-0117">Agreements and disagreements with other studies or reviews</h3> <p>We compared our meta‐analysis results with those from <a href="./references#CD006089-bbs2-0057" title="RosenfeldRM , SingerM , JonesS . Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology‐Head and Neck Surgery2007;137(3 Suppl):S32‐45. ">Rosenfeld 2007</a>, <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a>, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a>, <a href="./references#CD006089-bbs2-0034" title="FokkensWJ , LundVJ , MullolJ , BachertC , AlobidI , BaroodyF , et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology2012;50(1):1‐298. ">Fokkens 2012</a>, and <a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a>. </p> <p><a href="./references#CD006089-bbs2-0057" title="RosenfeldRM , SingerM , JonesS . Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology‐Head and Neck Surgery2007;137(3 Suppl):S32‐45. ">Rosenfeld 2007</a> included trials based on a clinical diagnosis, as well as trials that used technical investigations to establish the diagnosis (<a href="./references#CD006089-bbs2-0016" title="GanancaM , TrabulsiLR . The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo‐controlled study. Current Medical Research and Opinion1973;1(6):362‐8. ">Gananca 1973</a> (bacteriology); <a href="./references#CD006089-bbs2-0019" title="HansenJG , SchmidtH , GrinstedP . Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care2000;18(1):44‐7. ">Hansen 2000a</a> (elevated CRP or ESR); <a href="./references#CD006089-bbs2-0020" title="HayeR , LingaasE , HoivikHO , OdegardT . Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases1998;17(5):309‐12. ">Haye 1998</a> (radiography); <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> (CT); <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> (CT); <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a> (radiography). <a href="./references#CD006089-bbs2-0057" title="RosenfeldRM , SingerM , JonesS . Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology‐Head and Neck Surgery2007;137(3 Suppl):S32‐45. ">Rosenfeld 2007</a> excluded <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> because of a language barrier. <a href="./references#CD006089-bbs2-0015" title="WilliamsonIG , RumsbyK , BengeS , MooreM , SmithPW , CrossM , et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA2007;298(21):2487‐96. [PUBMED: 18056902] ">Williamson 2007</a> and <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> were not yet published. This study group found a modest antibiotic benefit for people with uncomplicated acute rhinosinusitis 7 to 12 days after entering a clinical trial (absolute risk difference 0.15, 95% CI 0.04 to 0.25; risk ratio 1.28, P = 0.007; NNTB 7), based on data from <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>, <a href="./references#CD006089-bbs2-0003" title="DeSutterAI , DeMeyereMJ , ChristiaensTC , VanDrielML , PeersmanW , DeMaeseneerJM . Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double‐blind controlled trial in family practice. Journal of Family Practice2002;51(4):317‐23. [PUBMED: 11978253] ">De Sutter 2002</a>, <a href="./references#CD006089-bbs2-0016" title="GanancaM , TrabulsiLR . The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo‐controlled study. Current Medical Research and Opinion1973;1(6):362‐8. ">Gananca 1973</a>, <a href="./references#CD006089-bbs2-0019" title="HansenJG , SchmidtH , GrinstedP . Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care2000;18(1):44‐7. ">Hansen 2000a</a>, <a href="./references#CD006089-bbs2-0020" title="HayeR , LingaasE , HoivikHO , OdegardT . Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases1998;17(5):309‐12. ">Haye 1998</a>, <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>, <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>, <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>, and <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>. However, there was a high level of heterogeneity (I² = 80%). The forest plot shows that the benefit of antibiotics is higher in studies with an inclusion based on specific technical investigations (bacteriology, diagnostic algorithm, including CRP, CT; (NNTB 3)). The risk difference of studies that enrolled participants with a negative imaging or based strictly on clinical criteria was 0.03 (95% CI ‐0.02 to 0.08; NNTB 12.5 to 50). This is in accordance with our results. At 14 to 15 days, there was no longer any statistical benefit (results based on data from <a href="./references#CD006089-bbs2-0002" title="BucherHC , TschudiP , YoungJ , PeriatP , Welge‐LuussenA , ZustH , et al. Effect of amoxicillin‐clavulanate in clinically diagnosed acute rhinosinusitis: a placebo‐controlled, double‐blind, randomized trial in general practice. Archives of Internal Medicine2003;163(15):1793‐8. [PUBMED: 12912714] ">Bucher 2003</a>; <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>; <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>; <a href="./references#CD006089-bbs2-0013" title="VanBuchemFL , KnottnerusJA , SchrijnemaekersVJ , PeetersMF . Primary‐care‐based randomised placebo‐controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet1997;349(9053):683‐7. ">Van Buchem 1997a</a>). Benefits were offset by a relative increase of 83% in adverse events (number needed to treat for an additional harmful outcome (NNTH) 9), which is similar to our calculations. </p> <p><a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> performed a IPDMA on clinically diagnosed acute rhinosinusitis. An IPDMA is the best way of performing subgroup analyses given that individual patient data from a number of RCTs can be obtained. As well as investigating the effect of antibiotics in the total group, the authors were able to investigate the effect of antibiotics in subgroups, such as people with at least seven days of rhinosinusitis‐like symptoms, as guidelines advocate prescribing antibiotics for this patient group (<a href="./references#CD006089-bbs2-0042" title="HicknerJM , BartlettJG , BesserRE , GonzalesR , HoffmanJR , SandeMA . Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine2001;134(6):498‐505. ">Hickner 2001</a>). <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> completed this IPDMA by further analysis of the effect of antibiotics in people with specific signs and symptoms, with the aim of identifying people who benefit most from antibiotic therapy. <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> included the same trials, except for <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a>, because they could not get the raw data for the IPDMA, and <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> because this trial was not yet published.<a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> included the raw data of <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> and of an identical unpublished trial run by Schering‐Plough. The estimated OR for the overall treatment effect of antibiotics relative to placebo was 1.37 (95% CI 1.13 to 1.66; NNTB 15, 95% CI 7 to 190, data IPDMA). The ORs of analyses of aggregated data of <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> were similar (OR 1.35, 95% CI 1.15 to 1.59). This OR for overall treatment effect in clinically diagnosed rhinosinusitis is slightly higher than in this review, probably due to the favourable results of <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>. <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> found that older people and people reporting severe symptoms or longer duration of symptoms (six days or more) took longer to cure but were no more likely to benefit from treatment than other people. For other patient‐reported symptoms (previous common cold or two stages of illness, pain on bending, unilateral facial pain, pain in the teeth, and purulent nasal discharge), estimates were not sufficiently precise to draw any conclusion about their prognostic value. Participants with purulent discharge in the pharynx, ascertained by a physician, seemed to cure more slowly and to have some non‐significant benefits from antibiotics (OR 1.60, 95% CI 0.95 to 2.76; NNTB 8, 95% CI 4 to 47). The same was found for people with a higher temperature (OR 1.28, 95% CI 0.87 to 1.88). As we did not have the raw data, we could not perform this subgroup analyses. <a href="./references#CD006089-bbs2-0065" title="YoungJ , DeSutterA , MerensteinD , vanEssenGA , KaiserL , VaronenH , et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta‐analysis of individual patient data. Lancet2008;371(9616):908‐14. ">Young 2008</a> did not investigate adverse events. </p> <p><a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> included trials in adults or children based on clinical diagnosis and/or specific technical investigations (extra trials: <a href="./references#CD006089-bbs2-0016" title="GanancaM , TrabulsiLR . The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo‐controlled study. Current Medical Research and Opinion1973;1(6):362‐8. ">Gananca 1973</a> (bacteriology); <a href="./references#CD006089-bbs2-0035" title="GarbuttJM , GoldsteinM , GellmanE , ShannonW , LittenbergB . A randomized, placebo‐controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics2001;107(4):619‐25. [PUBMED: 11335733] ">Garbutt 2001</a> (children); <a href="./references#CD006089-bbs2-0019" title="HansenJG , SchmidtH , GrinstedP . Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scandinavian Journal of Primary Health Care2000;18(1):44‐7. ">Hansen 2000a</a> (elevated CRP or ESR); <a href="./references#CD006089-bbs2-0020" title="HayeR , LingaasE , HoivikHO , OdegardT . Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology and Infectious Diseases1998;17(5):309‐12. ">Haye 1998</a> (radiography); <a href="./references#CD006089-bbs2-0046" title="KristoA , UhariM , LuotonenJ , IlkkoE , KoivunenP , AlhoOP . Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Acta Paediatrica2005;94(9):1208‐13. [PUBMED: 16278986] ">Kristo 2005</a> (children); <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> (CT); <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> (CT); <a href="./references#CD006089-bbs2-0062" title="WaldER , ChiponisD , Ledesma‐MedinaJ . Comparative effectiveness of amoxicillin and amoxicillin‐clavulanate potassium in acute paranasal sinus infections in children: a double‐blind, placebo‐controlled trial. Pediatrics1986;77(6):795‐800. [PUBMED: 3520469] ">Wald 1986</a> (children)).<a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> excluded <a href="./references#CD006089-bbs2-0010" title="NorrelundN . Treatment of sinusitis in general practice. A controlled investigation of pivampicillin (Pondocillin) [Behandling af sinuitis i almenpraksis. En kontrolleret undersogelse over pivampicillin (Pondocillin)]. Ugeskrift for Laeger1978;140(45):2792‐5. [PUBMED: 362655] ">Norrelund 1978</a> due to a language barrier. For <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> only took into account the subgroup of people with rhinosinusitis confirmed by radiography. <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> did not include <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> because this study was not yet published. <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> made a distinction between "cured or improved" and "cured". Considering the different definitions, "cure" or "improvement" seem to be a subjective interpretation of how a patient feels at one time point, expressed in resolution of symptoms, restriction in daily activities, or feeling cured; therefore, we did not choose to make this distinction in this review. Taking cure as an outcome measure, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> found a higher cure rate in people taking antibiotics compared to placebo (OR 1.82, 95% CI 1.34 to 2.46; NNTB 7, 95% CI 5 to 14). In this analysis, the diagnosis was made on clinical criteria only in only 4 of the 12 trials. <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> omitted the trials by <a href="./references#CD006089-bbs2-0005" title="KaiserL ,  MorabiaA ,  StalderH ,  RicchettiA ,  AuckenthalerR ,  TerrierF ,  etal . Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. European Journal of Clinical Microbiology and Infectious Diseases2001;20(7):445‐51. ">Kaiser 2001</a>, <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a>, <a href="./references#CD006089-bbs2-0012" title="StalmanW , vanEssenGA , van derGraafY , deMelkerRAC . The end of antibiotic treatment in adults with acute sinusitis‐like complaints in general practice? A placebo‐controlled double‐blind randomized doxycycline trial. British Journal of General Practice1997;47(425):794‐9. [PUBMED: 9463979] ">Stalman 1997</a>, and <a href="./references#CD006089-bbs2-0014" title="VaronenH , KunnamoI , SavolainenS , MakelaM , RevontaM , RuotsalainenJ , et al. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. A placebo‐controlled randomised trial. Scandinavian Journal of Primary Health Care2003;21(2):121‐6. [PUBMED: 12877377] ">Varonen 2003</a> because these trials did not report rates for cure (as defined by <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a>) separately. As in <a href="./references#CD006089-bbs2-0057" title="RosenfeldRM , SingerM , JonesS . Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology‐Head and Neck Surgery2007;137(3 Suppl):S32‐45. ">Rosenfeld 2007</a>, the forest plot revealed heterogeneity (I² = 50%): the trials with inclusion based on specific technical investigations (CT or laboratory tests) showed more benefit for antibiotics than the trials with inclusion on a clinical basis. Furthermore, taking cure or improvement as an outcome measure, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> found that people with rhinosinusitis benefit from antibiotics (OR 1.64, 95% CI 1.35 to 2.00; NNTB 11, 95% CI 8 to 17). However, for the <a href="./references#CD006089-bbs2-0008" title="MeltzerEO , BachertC , StaudingerH . Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Journal of Allergy and Clinical Immunology2005;116(6):1289‐95. [PUBMED: 16337461] SvenssonJ , LundbergJ , OlssonP , StjärneP , TennvallGR . Cost‐effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Primary Care Respiratory Journal2012;21(4):412‐8. ">Meltzer 2005</a> study, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> used the number of treatment failures as the number of people who were not cured, which makes the cure rate artificially high. Heterogeneity was low, but the same trend (more technical investigations, more benefit of antibiotics) can be seen. <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> put their positive result into perspective by comparing the NNTB of 7 (95% CI 5 to 14) to a NNTH (adverse events) of 9 (95% CI 5 to 30), a number that is, irrespective of the different kinds of studies included in the analysis, comparable to our results. <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a> found no significant difference in cure or improvement for adults versus children, imaging versus clinical criteria for inclusion, assessment at 7 to 11 versus 14 to 15 days, or year of publication. </p> <p><a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a> included original studies that compared treatment of any antibiotic with placebo in people with symptoms and signs of acute rhinosinusitis lasting for seven or more days. The reason given by <a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a> for this inclusion criterion was the recommendation of the 'European position paper on rhinosinusitis and nasal polyps' (<a href="./references#CD006089-bbs2-0034" title="FokkensWJ , LundVJ , MullolJ , BachertC , AlobidI , BaroodyF , et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology2012;50(1):1‐298. ">Fokkens 2012</a>). <a href="./references#CD006089-bbs2-0034" title="FokkensWJ , LundVJ , MullolJ , BachertC , AlobidI , BaroodyF , et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology2012;50(1):1‐298. ">Fokkens 2012</a> recommend antibiotic treatment only in people with duration of symptoms of more than 10 days; however, as no original study included this kind of participant, <a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a> used seven days or more as their criterion. Only <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a> (clinical criteria), <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a> (clinical criteria), <a href="./references#CD006089-bbs2-0018" title="HadleyJA , MosgesR , DesrosiersM , HaverstockD , vanVeenhuyzenD , Herman‐GnjidicZ . Moxifloxacin five‐day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope2010;120(5):1057‐62. ">Hadley 2010</a> (radiography and bacteriology), <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> (CT), and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> (CT) were selected. <a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a> looked separately at improvement and cure, finding a significantly higher proportion of people with improvement of symptoms after 3 and 7 days in people treated with antibiotics compared to placebo (OR 2.78, 95% CI 1.39 to 5.58 at day 3, based on data from <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>, <a href="./references#CD006089-bbs2-0018" title="HadleyJA , MosgesR , DesrosiersM , HaverstockD , vanVeenhuyzenD , Herman‐GnjidicZ . Moxifloxacin five‐day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope2010;120(5):1057‐62. ">Hadley 2010</a>, <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a>, and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>; and OR 2.29, 95% CI 1.19 to 4.41 at day 7, based on data from <a href="./references#CD006089-bbs2-0004" title="GarbuttJM , BanisterC , SpitznagelE , PiccirilloJF . Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA2012;307(7):685‐92. ">Garbutt 2012</a>). There was no relevant difference in the rate of cure at day 10 (OR 1.92, 95% CI 0.63 to 5.8, based on data from <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a>) or at day 14 (OR 1.57, 95% CI 0.79 to 3.13, based on data from <a href="./references#CD006089-bbs2-0009" title="MerensteinD , WhittakerC , ChadwellT , WegnerB , D'AmicoF . Are antibiotics beneficial for patients with sinusitis complaints? A randomized double‐blind clinical trial. Journal of Family Practice2005;54(2):144‐51. [PUBMED: 15689289] ">Merenstein 2005</a>). It was difficult to compare results because there was minimal overlap in pooled studies. Furtermore, we questioned if symptoms lasting for seven days or more is a good criterion for selecting participants who could benefit from antibiotics. <a href="./references#CD006089-bbs2-0049" title="LindbaekM , HjortdahlP . The clinical diagnosis of acute purulent sinusitis in general practice ‐ a review. British Journal of General Practice2002;52(479):491‐5. ">Lindbaek 2002</a> reviewed the clinical diagnosis of acute purulent sinusitis in general practice. The strongest predictor for the diagnosis of purulent sinusitis is the presence of purulent secretion in the nasal cavity. Pain in the teeth and an elevated ESR were associated in two of the four studies. Two phases in the illness history, ineffectiveness of decongestants and transillumination of the sinuses, might be of some value. We found no evidence that people with symptoms lasting seven days or more before consulting their physician are more likely to have bacterial sinusitis. Of the 440 people in <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> combined, 202/254 (80%) of people with CT‐confirmed sinusitis were symptomatic for more than seven days, while 131/186 (70%) of people without CT‐confirmed sinusitis were symptomatic for more than seven days. The difference is statistically significant (P = 0.03), but has not been analysed in a multivariate logistic regression. This means that about 60% of people presenting to general practices with sinusitis symptoms for more than seven days would have CT‐confirmed sinusitis, and 40% would have a prolonged viral infection. But of people presenting with symptoms of seven days or less duration, about 50% will have a CT‐confirmed sinusitis, and about 50% viral upper respiratory tract infections (<a href="./references#CD006089-bbs2-0050" title="LindbaekM . Illness duration of 7 days and purulent sinusitis: a question [personal communication]. Lemiengre MB, De Sutter AI 12 February 2015. ">Lindbaek 2015 [pers comm]</a>). Consequently, despite only 20% of people with CT‐confirmed sinusitis having symptoms for seven or fewer days (<a href="./references#CD006089-bbs2-0042" title="HicknerJM , BartlettJG , BesserRE , GonzalesR , HoffmanJR , SandeMA . Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Annals of Internal Medicine2001;134(6):498‐505. ">Hickner 2001</a>), duration of symptoms is a poor predictor of acute bacterial sinusitis. </p> <p>In conclusion, people with clinically diagnosed rhinosinusitis and rhinosinusitis confirmed by imaging (radiography, CT) or laboratory findings (CRP, bacteriology) constitute different groups, and we are convinced that they cannot be pooled in one analysis, as performed by <a href="./references#CD006089-bbs2-0029" title="BurgstallerJM , SteurerJ , HolzmannD , GeigesG , SoykaMB . Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. European Archives of Oto‐rhino‐laryngology2016;273(5):1067‐77. [DOI: 10.1007/s00405‐015‐3506‐z; PUBMED: 25597034] ">Burgstaller 2016</a>, <a href="./references#CD006089-bbs2-0032" title="FalagasME , GiannopoulouKP , VardakasKZ , DimopoulosG , KarageorgopoulosDE . Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta‐analysis of randomised controlled trials. Lancet Infectious Diseases2008;8(9):543‐52. ">Falagas 2008</a>, and <a href="./references#CD006089-bbs2-0057" title="RosenfeldRM , SingerM , JonesS . Systematic review of antimicrobial therapy in patients with acute rhinosinusitis. Otolaryngology‐Head and Neck Surgery2007;137(3 Suppl):S32‐45. ">Rosenfeld 2007</a>. The separate results are very relevant: when a clinician makes a clinical diagnosis, the one analysis is applicable; when a decision is made to confirm the diagnosis by imaging, the other analysis is applicable. This would be clear for any clinician and avoids confusion. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006089-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006089-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006089-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006089-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Antibiotics versus placebo in acute rhinosinusitis, outcome: 1.1 Cure." data-id="CD006089-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antibiotics versus placebo in acute rhinosinusitis, outcome: 1.1 Cure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis whether or not confirmed by imaging, outcome: 2.2 Side effects: general." data-id="CD006089-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis whether or not confirmed by imaging, outcome: 2.2 Side effects: general. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, outcome: 2.4 Clinical failure." data-id="CD006089-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, outcome: 2.4 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotics versus placebo for acute rhinosinusitis: cure, Outcome 1 Cure." data-id="CD006089-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotics versus placebo for acute rhinosinusitis: cure, Outcome 1 Cure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 1 Severity or duration of different clinical symptoms: resolution of purulent secretion." data-id="CD006089-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 1 Severity or duration of different clinical symptoms: resolution of purulent secretion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 2 Side effects: total." data-id="CD006089-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 2 Side effects: total. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 3 Side effects: diarrhoea." data-id="CD006089-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 3 Side effects: diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-002-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 4 Clinical failure." data-id="CD006089-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes, Outcome 4 Clinical failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Sensitivity analyses, Outcome 1 Clinically diagnosed rhinosinusitis." data-id="CD006089-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Sensitivity analyses, Outcome 1 Clinically diagnosed rhinosinusitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006089-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/urn:x-wiley:14651858:media:CD006089:CD006089-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_t/tCD006089-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Sensitivity analyses, Outcome 2 Rhinosinusitis confirmed by imaging." data-id="CD006089-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Sensitivity analyses, Outcome 2 Rhinosinusitis confirmed by imaging.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/media/CDSR/CD006089/image_n/nCD006089-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006089-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to placebo for acute rhinosinusitis in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antbiotics compared to placebo for acute rhinosinusitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute rhinosinusitis in adults, whether clinically diagnosed or confirmed by imaging<br/> <b>Settings:</b> general practice (11 studies), otolaryngology outpatient clinics of university hospitals (2 studies), medical centre (1 study), unknown (2 studies)<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with clinically diagnosed acute rhinosinusitis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b><br/> (56 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.25</b> <br/> (1.02 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1687<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combination of sinusitis‐like symptoms. Most frequently used clinical symptoms: nasal discharge, facial pain, and common cold or upper respiratory tract infection. </p> <p>NNTB 19 (95% CI 10 to 205)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with acute rhinosinusitis confirmed by radiography<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 100</b> </p> <p>(52 to 72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.57</b> </p> <p>(1.03 to 2.39)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>394</p> <p>(3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>Moderate<sup>2, 3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical suspicion + radiography, using various criteria:</p> <p> <ul id="CD006089-list-0001"> <li> <p>confirmed secretion;</p> </li> <li> <p>&gt; 5 mm mucosal thickening, opacity or fluid level; or</p> </li> <li> <p>the presence in at least 1 sinus of an air‐fluid level, a complete opacity, or a mucosal thickening of 10 mL. </p> </li> </ul> </p> <p>NNTB 10 (95% CI 5 to 136)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cure in adults with acute rhinosinusitis confirmed by computed tomography<sup>1,4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 100</b> </p> <p>(18 to 64)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 4.89</b> </p> <p>(1.75 to 13.72)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>5</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical suspicion + computed tomography, using as a criterion presence of fluid level or total opacification in any sinus </p> <p>NNTB 4 (95% CI 2 to 15)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severity or duration of different clinical symptoms: resolution of purulent secretion</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 100</b><br/> (63 to 77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.58</b> <br/> (1.13 to 2.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>660<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTB 10 (95% CI 6 to 35)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects: total</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 100</b><br/> (24 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.21</b> </p> <p>(1.74 to 2.82)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1816<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 8 (95% CI 6 to 12)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects: diarrhoea</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 100</b><br/> (13 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 2.00</b> </p> <p>(1.41 to 2.85)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1210<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 13 (95% CI 8 to 29)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical failure</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 100</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 100</b><br/> (4 to 8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Peto OR 0.48</b> </p> <p>(0.36 to 0.63)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2603<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 19 (95% CI 15 to 27)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NNTB:</b> number needed to treat for an additional beneficial outcome; <b>NNTH:</b> number needed to treat for an additional harmful outcome; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Only outcomes that could be pooled were presented.</p> <p><sup>1</sup>High heterogeneity (I² = 41%) for the outcome of cure in adults with acute rhinosinusitis confirmed by imaging led us to split the outcome into cure in adults with acute rhinosinusitis confirmed by radiography and cure in adults with acute rhinosinusitis confirmed by computed tomography.<br/> <sup>2</sup>There was a high risk of blinding bias in <a href="./references#CD006089-bbs2-0001" title="AxelssonA , ChidekelN , GrebeliusN , JensenC . Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngologica1970;70(1):71‐6. ">Axelsson 1970</a>. Blinding was not reported and was probably not applied. Placebo group participants did not receive tablets, only nose drops. It was not possible to blind sinus irrigation as an intervention. Only group 2 participants underwent radiological evaluation every second day. Group 3 participants received a longer course of tablets than group 4. For this reason, we downgraded the quality of evidence from high to moderate. Omitting this trial from the meta‐analysis did not substantially change the overall result; therefore, we did not downgrade the quality of the evidence further.<br/> <sup>3</sup>Three trials reported cure in adults with acute rhinosinusitis confirmed by radiography, and confidence intervals were wide. We downgraded the quality of the evidence to moderate.<br/> <sup>4</sup><a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> and <a href="./references#CD006089-bbs2-0007" title="LindbaekM , KaastadE , DolvikS , JohnsenU , LaerumE , HjortdahlP . Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut‐off points in sinus CT. Rhinology1998;36(1):7‐11. ">Lindbaek 1998</a> presented study results from two distinct groups (those with fluid level or total opacification in any sinus on computed tomography and those with only mucosal thickening on computed tomography, respectively). Consequently, the results of the two trials were very different (I² = 84%). We opted to report only the results from <a href="./references#CD006089-bbs2-0006" title="LindbaekM , HjortdahlP , JohnsenULC . Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325‐9. ">Lindbaek 1996</a> because the beneficial effect of antibiotics was clearly present only in this subgroup.<br/> <sup>5</sup>Only one trial (N = 127) reported on cure in adults with acute rhinosinusitis confirmed by computed tomography. We downgraded the quality of the evidence to moderate because of the low number of participants despite this being a well‐conducted trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared to placebo for acute rhinosinusitis in adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/full#CD006089-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006089-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus placebo for acute rhinosinusitis: cure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.15, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Clinically diagnosed acute rhinosinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.02, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Acute rhinosinusitis confirmed by radiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.03, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Acute rhinosinusitis confirmed by computed tomography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.89 [1.75, 13.72]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotics versus placebo for acute rhinosinusitis: cure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006089-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Severity or duration of different clinical symptoms: resolution of purulent secretion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.13, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Side effects: total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [1.74, 2.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Clinically diagnosed rhinosinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.60, 2.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Rhinosinusitis confirmed by imaging</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.65 [1.58, 4.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Side effects: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.41, 2.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.36, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Clinically diagnosed rhinosinusitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.36, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Rhinosinusitis confirmed by radiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [0.52, 8.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Rhinosinusitis confirmed by computed tomography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.11, 0.55]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotics versus placebo in acute rhinosinusitis: secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006089-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sensitivity analyses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinically diagnosed rhinosinusitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [1.14, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cure at 1 week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.81, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Cure at 10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.92, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Cure at 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.98, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Cure at 1 week, with Garbutt data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.93, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Cure at 10 days, with Garbutt data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.91, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Influence of missing data: cure at any time point if dropouts were successes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1785</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.02, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Influence of missing data: cure at any time point if dropouts were failures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1785</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.02, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Influence of missing data: cure at any time point if dropouts had the same cure rate as control group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1785</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.02, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9 Influence of missing data: cure at 1 week if dropouts were successes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.79, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10 Influence of missing data: cure at 1 week if dropouts were failures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.84, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11 Influence of missing data: cure at 1 week if dropouts had the same cure rate as control group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.79, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12 Influence of missing data: cure at 10 days if dropouts were successes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.94, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13 Influence of missing data: cure at 10 days if dropouts were failures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.94, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14 Influence of missing data: cure at 10 days if dropouts had the same cure rate as control group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.93, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15 Influence of missing data: cure at 2 weeks if dropouts were successes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1026</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.98, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16 Influence of missing data: cure at 2 weeks if dropouts were failures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.99, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17 Influence of missing data: cure at 2 weeks if dropouts had the same cure rate as control group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.99, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18 Overall treatment effect (with Young 2008 data concerning Stalman)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.04, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Rhinosinusitis confirmed by imaging <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1086</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.41, 2.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cure at any time point</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [1.20, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Cure or improvement at any time point</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [1.35, 3.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Sensitivity analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006089.pub5/references#CD006089-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006089.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006089-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006089-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006089-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006089-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006089-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006089-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD006089-note-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006089-note-0002">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006089-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006089\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006089\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006089\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006089\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006089\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006089.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006089.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006089.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006089.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006089.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728737391"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006089.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728737395"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006089.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecbc5debcf56f',t:'MTc0MDcyODczOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 